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Abstract  
 
 
The genus Listeria comprises bacteria that are ubiquitous and commonly present in 
food production facilities. Even though Listeria monocytogenes is the only Listeria 
species with relevance in causing listeriosis, many new Listeria species have been 
described in the recent years increasing the importance of studies over the genus. In 
this study, phage display technologies were employed to discover, identify, and 
characterize novel biomarkers and monoclonal antibodies. In brief, antibody phage 
display was applied to select antibodies against subcellular fractions of L. 
monocytogenes. Then, the target of the antibodies was identified by ORFeome phage 
display and confirmed with immunomagnetic separation-mass spectrometry (IMS-MS). 
Dihydrolipoamide acetyltransferase (pyruvate dehydrogenase complex - enzyme 2, 
PDC-E2) was identified as the target of the initial antibodies against Listeria spp.. 
Immunoblot and microscopy showed that this protein is present on the bacterial cell 
surface and is detectable in fluorescent microscopy. In addition, recombinant 
antibodies were generated against already known targets (internalins A and B, and 
fructose bisphosphate aldolase). In total, a set of five scFv-Fc against L. 
monocytogenes and 22 against Listeria spp. were tested in indirect ELISA against 17 
Listeria and 15 non-Listeria species. All the five scFv-Fc against the pathogenic 
species showed 100 % sensitivity (CI 88.78-100.0 %) and specificity (CI 88.78-100.0 
%), while the two anti-fructose bisphosphate aldolase showed non-optimal diagnostic 
performance. On the other hand, two antibodies against PDC-E2 (anti-Listeria spp.) 
showed 100 % sensitivity (CI 82.35-100.0 %) and specificity (CI 78.20-100.0 %), 
confirming PDC-E2 as a suitable detection target for Listeria spp.. Furthermore, the 
binding regions of two hibridoma-derived antibodies and the scFv-Fc against PDC-E2 
were defined via single gene phage display, showing that this technique can provide 
information over the recognized region of a target in a considerable resolution. In 
addition, it revealed that the two best anti-PDC-E2 antibodies are the only ones to bind 
a synthetic region composed of two parts of PDC-E2. Hence, through a particular 
combination of phage display techniques, the biomarker PDC-E2 and two 
corresponding scFv-Fc against it, as well as scFv-Fc against internalins A and B, are 
hereby reported as novel promising tools for Listeria spp. detection. 
 
Keywords: phage display, monoclonal antibodies, Listeria spp., immunodetection, 
pyruvate dehydrogenase complex  
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1 INTRODUCTION 
 
1.1 Monoclonal antibodies and phage display 
Currently, mAbs are the most valuable biological molecule, representing the 
biggest market. Because of that, most of the phage display works are focused on 
generating antibodies for basic research, diagnostics, and, more importantly, 
therapeutic applications (Schirrmann et al., 2011; Nixon et al., 2014; Frenzel et al., 
2016; Kuhn et al., 2016; Strohl, 2018). Some variations of the technology, such as the 
ORFeome phage display, can be employed for the discovery of biomarkers, which can 
further be used for the development of vaccines and diagnostics (Zantow et al., 2016; 
Zantow et al., 2018). While other variations, like the single gene phage display, can be 
used to finer characterize epitopes of antibodies (Moreira et al., 2018; Fühner et al., 
2019). Considering this, phage display shows to be a flexible technology that allow 
obtaining both antibodies and biomarkers for product development, as well as having 
further information regarding their recognition profile. 
 
1.1.1 Antibody structure and formats 
 In nature, several antibody structures exist, showing different functions in a 
single organism, or having homologous function but distinct formats between different 
species. In higher mammals, such as humans, antibodies can be produced as IgA, 
IgD, IgE, IgG, and IgM (Figure 1). Each of these structures have specific functions in 
the body, i.e. IgA is mostly present in mucosal tissues, IgD and IgM are the ones firstly 
produced from B-cells in an immune response, IgE is predominantly involved in allergic 
responses, and IgG is the most abundant antibody in circulation, responsible for the 
most specific immune responses (Murphy et al., 2007). Due to its specific recognitions 
and broad range of functions in the immune response, the IgG is the most studied and 
applied antibody structure in the immunology field (Chiu & Gilliland, 2016; Elgundi et 
al., 2017). This way, most of the molecules developed for treatment, research, or other 
biological applications use this structure or a similar one that keeps its functions. The 
other antibody formats are also used, but in a much lesser extent. 
 15 
 
 
Figure 1. Representation of antibody structures occurring in higher mammals and humans. The binding 
region of the antibodies is shown in shades of red. The IgM structure (top left panel) is a pentameric 
protein in which the monomers are connected with disulfide bonds and a J-chain (junction chain, yellow). 
The IgA (top right panel) is a dimeric antibody also connected with H-bonds and a J-chain. Additionally, 
this structure contains a secretory protein (not shown) for secretion in mucosal tissues. The IgE structure 
(bottom left panel) is monomeric and has a longer heavy chain, which is comparable to a monomer of 
IgM. The IgG and IgD structures (bottom center and right panel) are monomeric, comparable to a single 
unit of IgA, and differ slightly on their disulfide bond pattern in the constant parts. Among these 
structures, the IgG is the most common representation of antibodies, especially due to its immunological 
importance. 
 
 Although the antibodies in nature, such as the IgG, show to be the optimal 
molecules for either therapy or other fields, it is important to consider that they are 
complex and, thus, may not be applicable in some techniques. The IgG structure is 
comprised by four chains (two heavy and two light chains), which form a tetrameric 
structure (Figure 2). Within this structure, there is also the formation of disulfide bonds 
that increase the stability of the molecule, but also its complexity. Nevertheless, by 
knowing the function of each region of the antibodies, it is possible to elaborate 
strategies for reducing its complexity (Frenzel et al., 2016). Its fragment crystallizable 
(Fc), which is responsible to interact with receptor in effector cells of the immune 
system, determines the function of each antibody depending on the class of Fc. While 
the fragment antigen-binding (Fab) is the one promoting the interaction of the antibody 
with an antigen. In the Fab there are regions with high genetic variability, one in the 
heavy chain and one in the light chain, that compose the fragment variable (Fv). Within 
the Fv, the interaction with the antigen occurs though specific amino acid sequences 
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of the antibody, called complementarity-determining regions (CDR), which are loops 
that structurally form a region of the antibody called the paratope. The paratope 
comprises six different loops (three from each heavy and light chains), and are the 
structural counterpart of the epitope, which in turn is the recognized structure region of 
an antigen (Schroeder et al., 2010). 
 
Figure 2. Representation of the different structural parts of an antibody. The antibody structure can be 
understood regarding its protein assembly (top left panel), which involves two heavy chains (blue) and 
two light chains (red). It also can be defined regarding the function of the different parts (top right panel), 
which can be for antigen binding (Fab, golden) or effective responses (Fc, green). The antibody can 
also be understood regarding its genetic variability (bottom left panel), with variable (Fv, purple) and 
constant (yellow) regions. Within the Fv (bottom right panel), it is also possible to define hypervariable 
regions (CDR, light green) and less variable ones, called framework regions (dark blue). 
 
Considering that the CDR promote recognition of a target, it is possible to define 
a minimal structure of the antibody needed for its binding. Such structure comprises 
the Fv of the heavy chain (VH) and light chain (VL). This way, by connecting both VH 
and VL in the same molecule, it is possible to recreate the minimal structure of a native 
antibody in a functional manner (Figure 3). The antibody containing connected VH and 
VL is called single chain fragment variable (scFv) and is small enough to be produced 
in less complex organisms, such as in prokaryotic cells (Bradbury et al., 2011). This 
way, scFv is nowadays the molecule of choice for most of the display methods that 
involve selection of antibodies in library scale, such as phage display. Nevertheless, 
smaller formats can also be studied, such as the single-domain antibody (sdAb). These 
antibodies comprise only the VH as binding molecule and were firstly studied in camelid 
 17 
 
antibodies (VHH), which do not possess the VL counterpart in their structure (Arbabi-
Ghahroudi, 2017). In fact, it is known that the major part of the paratope of antibodies 
relies on the VH for binding, while the VL usually has smaller contribution or only 
stabilizing function (D’Angelo et al., 2018). 
 Even though it is interesting to have functional and small versions of antibodies, 
it is important to be able to alter their structure and control their action according to the 
need. Considering this, a vast amount of antibody formats that are not present in nature 
have been developed, giving the opportunity to simply transfer the VH and VL 
sequences to a pre-defined scaffold. When considering in vitro methods that use 
recombinant antibodies, it is possible to identify a tendency in which antibodies are 
selected in smaller formats, and then used in this way or transferred to other formats 
that suit their application (Jostock et al., 2004; Frenzel et al., 2017). One of the simplest 
formats that add function to selected scFv, for example, is the scFv-Fc, which 
comprises the addition of an Fc part to the molecule allowing it to execute its effector 
functions (Figure 3). Another very common format is the IgG itself, which is used to 
reconvert the initially selected antibodies to their “similar-to-original” structure. 
Nevertheless, considering that scFv-Fc and IgG are more complex, they must be 
produce in other systems, mainly mammalian or other eukaryotic cells (Jäger et al., 
2013; Lalonde & Durocher, 2017). In this document, scFv-Fc and IgG will gain more 
attention, since the list of possible formats, mainly bispecific, is extremely big and is 
still growing (Brinkmann & Kontermann, 2017). 
 
Figure 3. Comparison of non-natural antibody structures to that of IgG. From left to right, the structures 
of IgG, scFv-Fc, scFv, and sdAb represent the possibility of reducing the structure complexity of 
antibodies while keeping their binding function. For this, it is noticeable that the VH (red) and VL 
(burgundy) are the important parts, mainly the former. In case the application of the antibody requires 
an effector function, the Fc part is usually included or kept. 
 
 
 18 
 
1.1.2 Kinds of phage display and panning procedures 
 In the field of proteomics, different technologies have arose to study protein 
molecules, such as antibodies or antigens, in library scale (Galán et al., 2016). These 
display methods consist on attaching the genetic information (genotype) to its encoded 
protein product (phenotype) that, in turn, is displayed on a certain part of the system. 
In this case, such protein products can be displayed on ribosomes, bacteria, yeasts, 
mammalian cells, phage, or other biological and chemical components. The main 
difference between these systems is regarding the amount of different molecules that 
can be included in the libraries and the capacity of performing posttranslational 
modifications in the displayed molecules. Among these options, phage display is 
nowadays the most applied method not only to select antibodies against interesting 
targets, but also to identify antigens recognized by antibodies (Kügler et al., 2013; 
Nixon et al., 2014). This way, phage display can be applied for antibody generation, 
allowing the development of therapeutic molecules and diagnostic tests, as well as for 
the discovery of biomarkers, which can serve as diagnostic or vaccine targets. 
 When using the phage display system, different molecules, such as antibodies, 
antigen fragments, or peptides, can constitute the library. Currently, the filamentous 
phage M13 system is the most used, since this is a non-lytic phage that can be easily 
handled though the infection of E. coli. In the structure of M13 phage, there are many 
structural proteins, from which the minor protein III (pIII) can be highlighted (Ledsgaard 
et al., 2018). This protein is located in one of the extremes of the phage and presented 
in a fixed amount, limited to five copies per phage. Due to this, pIII is nowadays the 
molecule of choice to fuse proteins to be displayed on the phage surface (Paschke & 
Höhne, 2005). The current method for displaying proteins on a phage employs a DNA 
molecule called phagemid (Figure 4). This molecule is a circular extrachromosomal 
genetic material similar to a plasmid that contains a packaging signal for M13 phage, 
a selective marker gene for E. coli, and restriction sites that allows the fusion of DNA 
fragments in-frame with the coding gene for pIII (Breitling et al., 1991). This way, when 
a phagemid is inserted into E. coli, the fusion molecule is produced and used to build 
the phage particle, resulting in an exposed product of the inserted gene. Other feature 
of the phagemid is that the molecules produced have the pelB peptide, which directs 
the protein to the periplasmic space. In case of producing antibodies, this fact is very 
important considering that this environment is more prone for the formation of disulfide 
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bonds needed to stabilize the antibody (Skerra & Pluckthun, 1988). A lac promoter 
usually regulates the gene cassette. In addition, the phagemid also contains an Amber 
stop codon between the inserted gene fragment and the pIII gene. This stop codon 
can be recognized as a coding codon for Glutamine (Gln, Q) when using Amber-
suppressor E. coli strains (Krebber et al., 1996). This way, the phagemid allow the 
production of both the pIII fusion protein and the cloned fragment alone, increasing the 
possible assays with the same phagemid system. 
 
Figure 4. Use of the phagemid system for phage display. Initially, a source of genes or gene fragments 
is necessary (top panel). This genetic material is then inserted in the phagemid (middle panel) containing 
a proper cassette, including a promoter (green), a pelB periplasm signal, a cloning site (red), an Amber 
stop codon, and gIII. If the genetic material is inserted in frame with gIII, the phagemid is able to provide 
a functional phage displaying the encoded product of it (bottom), e.g. part of an antigen, or a scFv 
antibody. Other features of the phagemid are an origin of replication in E. coli (colE1), a selection marker 
gene (bla), and a phage packaging signal (M13 ori). 
 
When a phagemid is inserted into E. coli, however, it is still not possible to 
produce infective phage particles. For this, it is necessary to use a so-called 
helperphage, which is able to infect E. coli delivering the other structural genes needed 
to build a functional phage, including the native pIII gene (Soltes et al., 2007). 
Nevertheless, the use of this phage also leads to the generation of phage that do not 
contain the fusion protein target::pIII, once the native pIII has natural preference when 
building phage. To overcome this problem, a very interesting advance for the phage 
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display technology was done by using a helperphage with the pIII gene knocked out, 
the so-called Hyperphage (Rondot et al., 2001). Among the advantages of using 
Hyperphage is the major production of phage containing only the target::pIII fusion 
protein, which reduces the amount of “junk phage” (phage displaying wrongly produced 
fusion proteins, or no fusion protein at all) in the library. Furthermore, since the only 
source of pIII is the fusion protein, each phage usually presents more than one 
molecule of the target on its surface (up to five), giving an avidity effect for the 
components of the library that increases the chance of selecting relevant molecules. 
 After inserting many different DNA fragments in-frame with pIII and building 
functional phage displaying the product of the information carried in their phagemids, 
a phage library is obtained. Considering that many of the phage in the library may not 
contain relevant molecules for a certain study, an approach for the selection of the 
interesting ones must be performed. This method is called panning, referring to “gold 
panning”, which is a procedure of collecting gold using a pan. In this approach, a target 
molecule is incubated together with the library to promote the interaction between 
these two parts (Frenzel et al., 2017). This step can be done by immobilizing the target 
molecule on a surface, e.g. an ELISA plate or magnetic beads, and adding the library 
afterwards (Figure 5). Then, the non-bound phage is washed away, and the ones that 
interact with the target are eluted, usually with proteases or chemical changes, such 
as pH. This eluted phage is used to infect E. coli, which is further co-infected with a 
helperphage, allowing the enrichment of the selected phage. The enriched phage are 
then used for further rounds of selection through the same procedure, usually one or 
two more, resulting in molecules with high specificity to the target. Then, the selected 
phage are screened to confirm the interaction with the target through an immunoassay, 
usually ELISA. Finally, the phagemids of the clones showing positive reaction in the 
screening are sequenced, allowing the identification of relevant sequences (Moreira et 
al., 2018; Zantow et al., 2018; Russo et al., 2018). 
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Figure 5. Steps of the panning procedure and screening of relevant molecules. Once the phage library 
are built containing either antigen or antibody sequences (1), they are further incubated with their targets 
(2), which can be either an antibody or antigen. The unbound phage from the library is washed away 
(3), while the bound ones are eluted and used to infect E. coli (4). The same cells are co-infected with 
helperphage (5) and grown for phage amplification of the selected binders (6). After the appropriate 
number of panning rounds, which can be 1 to 3, the E. coli cells infected with the eluted phage are 
picked individually, grown for the production of the selected molecules (7), and used in screening 
procedures such as ELISA (8). After sequencing of the positive clones in the screening, it is possible to 
identify the antigen, or parts of it, as well as antibody sequences for further applications. 
 
 When using the phage display technology, the library construction and panning 
procedures must be performed regardless of the molecules used as target or to build 
the library. Nevertheless, when using either antibodies or antigens in the library imply 
some relevant differences on the way the library is build and, more importantly, on the 
way the panning is performed. On the next paragraphs, the most common kinds of 
phage display approaches will be addressed. 
 
Antibody phage display 
 As mentioned previously, the scFv is a structure that contains the binding 
sequences of antibodies and are simple enough to be produced in prokaryotic 
systems. This way, this molecule is the mostly applied in phage display, which uses 
the bacterium E. coli as intermediate for the library construction and panning 
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procedure. To use antibodies in phage display, multiple DNA fragments coding for 
scFv are inserted in the phagemid and then used to build a library (McCafferty et al., 
1990; Kügler et al., 2018). Considering this, it is possible to distinguish different kinds 
of antibody library regarding the source of the antibody genes.  
A very useful kind of antibody phage library can be built by using antibody genes 
from immature B-cells, which did not yet went through mutations that increase its 
specificity against a certain target (Vaughan et al., 1996; Kügler et al., 2015). In this 
library, the VH genes originated from IgM or IgD from circulating immature B-cells are 
used together with VL genes to build a “naïve antibody library”. This kind of library is 
the most recommended when many different antigens are being studied, since the 
antibodies contained in it represent the repertoire of immature B-cells and, thus, can 
bind to virtually every antigen. 
Another kind of antibody library is the so called “immune antibody library”. In this 
case, the genetic information of the VH is acquired from mature B-cell, i.e. those that 
were already selected for specificity against a certain target. This way, this kind of 
library contain sequences mostly derived from IgG and often results in antibodies with 
higher affinity than those from naïve libraries (Soon Lim & Khim Chan, 2017). The use 
of this library is indicated when it is possible to induce immune responses against a 
defined target, allowing later on to acquire the genetic information of the generated 
antibodies (Kumar et al., 2019). 
Differently from the naïve and immune libraries, the “semi-synthetic or synthetic 
antibody library” does not use sequence directly obtained from B-cells. Instead, the 
sequences of the antibodies are randomly generated by changing the sequences 
contained in the CDR, mainly in the CDR3 of the VH, via PCR, or by shuffling the 
framework regions (Ponsel et al., 2011). These libraries are indicated when a target is 
low immunogenic, such as cancer antigens. 
When using any of these antibody libraries, the panning procedure is performed 
in very similar ways. In this case, the antigen is immobilized and the library is used in 
solution. Regarding the antigens used, they can be of two kinds: complex mixtures, or 
pure. In the first case (Figure 6A), the selected antibodies can serve as tool to detect 
new or relevant targets that were not initially separated from a mixture (Paoli et al., 
2004; Kuhn et al., 2017). On the other hand, using purified targets (Figure 6B) simply 
implies a procedure to acquire antibodies to be used as tools for research, detection, 
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or treatment (Kuhn et al., 2016). Depending on the protocol used for the removal of the 
unbound phage, binders with better affinity can be selected. Moreover, considering 
that the library usually contains several millions of different binders, an average of three 
panning rounds are necessary to ensure the selection of specific antibodies. More 
rounds may be added depending on the need or application (Moreland et al., 2012). 
Once the phage are selected, the screening is also conducted with the antibodies in 
solution, what is possible due to the pelB and Amber stop codon functions. 
 
Figure 6. Panning formats using antibody libraries. (A) Use of antibody libraries against a complex 
antigen mixture. Besides allowing the generation of antibodies, this application also allows the discovery 
of targets that were not previously separated from a mixture. (B) Use of antibody libraries against a pure 
antigen. This represents the most common application of antibody panning, resulting in a panel of 
different antibodies to be used in different applications. 
 
This kind of phage display can be compared to the classical method of obtaining 
antibodies, which uses the hibridoma technology. Although many advances have been 
done to improve hibridoma technology, the research over recombinant antibodies turn 
the use of phage display much bigger (Debs et al., 2012; Basu et al., 2019). This is 
because phage display can provide a large number of useful molecules in a short time 
and, besides this, can avoid the use of animals or biological material from patients. For 
this reason, antibody phage display is currently the method that mostly provides 
molecules for clinical applications (Frenzel et al., 2016). 
 
ORFeome phage display 
 Besides performing selection of antibodies, phage display can be also applied 
for the selection and identification of antigens. In fact, the initial descriptions of this 
technique involved the display of antigen peptides that would be further incubated with 
antibodies (Smith, 1985). In this context, similarly to the case of antibodies, antigen 
libraries can have different DNA sources. When building libraries of prokaryote 
 24 
 
organisms, the genomic DNA can be directly used once they have low amount of non-
coding DNA, and do not contain introns (Connor et al., 2016). For eukaryotes, usually 
the mRNA is used, since it represents a source of genetic material without introns. 
Nevertheless, the mRNA do not represent the totality of antigens that can be produced 
by the organism, but the antigens that are specific to the tissue or group of cells 
employed in the experiment (Becker et al., 2015). In both cases, the genetic material 
used for the library comprise fragmented genes and, thus, represent a repertoire of 
ORF from a genome, leading to the name of the technique (Hust et al., 2006). 
 Although similar to the antibody phage display, the panning procedure with 
ORFeome phage display has its particularities. One is that the antibodies used as 
counterpart of the antigens in the library are initially immobilized on a surface. When 
using polyclonal antibodies (Figure 7A), it is worth to consider that antibodies that are 
low represented may not be able to be immobilized or provide detectable binders in 
the screening (Gazarian et al., 2013; Zantow et al., 2016). When using monoclonal 
antibodies (Figure 7B), however, this effect may not happen (Chikaev et al., 2015; G. 
Moreira et al., 2018). Regardless of the kind of antibodies used, it is often 
recommended to perform several panning rounds, similar to what happens for antibody 
phage display, in order to enrich antigen phage from the initial library. Another 
particularity is that it is recommended to invert the system during the screening, using 
the coated antigen (usually in the phage form) and the antibodies in solution in a way 
to avoid binding problems due to the immobilization of antibodies. This phage display 
technology is often used for the discovery of immunogenic antigens that can be used 
as diagnostic tool or vaccine target. When using monoclonal antibodies, it can also be 
used for target identification, since it gives information about the target of the studied 
antibody (Kügler et al., 2013; Aghebati-Maleki et al., 2016). 
 
Figure 7. Panning formats using ORFeome libraries. (A) Use of ORFeome libraries against polyclonal 
antibodies. This procedure permits the identification of interesting targets that interact with antibodies 
from animal or human samples. (B) Use of ORFeome libraries against a monoclonal antibody. The 
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output of this approach gives information about the target of the studied antibody, which is important 
when the target is previously unknown. 
 
 Another technique that can provide results similar to the ORFeome phage 
display is the two-dimensional polyacrylamide gel electrophoresis followed by mass 
spectrometry (2D-PAGE/MS) (DelVecchio et al., 2006; Meens et al., 2006). In this 
technique, a protein extract from a target organism is used to perform a 2D-PAGE. 
Then, a polyclonal antibody is used to detect immunogenic proteins that are further 
identified in MS and may be relevant for the application of interest. Nevertheless, the 
main limitation of this method is regarding the source of protein, which usually relies 
on in vitro cultivation that rarely reproduces the protein profile in the environment. Other 
techniques for the same purpose can be the peptide/protein array (Schirwitz et al., 
2012) or lithic phage display (Lodes et al., 2004; Beghetto et al., 2006). However, the 
former shows to be a very expensive and laborious method, since it involves the 
production of several thousands of proteins individually. While the latter shows several 
practical disadvantages due to the use of lithic phage and has been applied mostly for 
cancer studies (Minenkova et al., 2003; Chen et al., 2005). 
 
Single gene phage display 
 Unlike the ORFeome phage display, the single gene phage display is often used 
when the studied antigen is already known (Cariccio et al., 2016). For example, when 
a panel of antibodies against one target needs to be analyzed regarding their binding 
region on the antigen, a single gene library alone can be used to study all the 
antibodies. It is expected that this procedure result in a higher resolution of the binding 
site when compared to ORFeome phage display, since the library size is often more 
than enough to cover a single gene and, thus, results in more different fragments of 
the same target to be analyzed. Because of that, this approach is also very useful for 
defining epitopes of antibodies. When monoclonal antibodies are used (Figure 8A), 
this approach involve a pair of antibody-antigen that are very likely to result in positive 
hits and, thus, only one panning round is usually needed (Fack et al., 1997; Fühner et 
al., 2019). On the other hand, when polyclonal antibodies are used (Figure 8B), it may 
be necessary to perform more rounds in order to confirm the selected clones or enrich 
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those who are present in lower amounts after selection (Domina et al., 2014). In this 
latter case, the results might provide regions of the studied antigens that are 
predominant on generating antibodies. 
 
Figure 8. Panning formats using single gene libraries. (A) Use of single gene libraries against a 
monoclonal antibody. The results of this technique allow defining the specific region of an antigen that 
is bound by an antibody. If the resolution of the output is high enough, it is possible to define the epitope 
of a panel of antibodies against the same target. (B) Use of single gene libraries against polyclonal 
antibodies. This approach gives information of parts of the antigen that are more prone to stimulate the 
generation of antibodies by the immune system. 
 
 Techniques other than phage display can also give results similar to that of the 
single gene panning approach. Until the present, X-ray co-crystallography is 
considered the optimal technique for defining epitopes, since it can give results with 
atomic resolution (Augustin et al., 2015; Malito et al., 2015). However, not every 
research facility is able to perform such experiments. Alternatively, methods using MS 
can be used, although they also employ special equipment. The most common 
procedures using MS are called “excision” and “extraction” (Opuni et al., 2018). In the 
former, antigen and antibody interact and are incubated for the digestion of the antigen. 
Then, the non-interacting parts of the antigen are washed, while the interacting ones 
are eluted and analyzed in MS. The latter is similar, but involves the incubation of the 
already digested antigen with the antibody and further analysis of the bound peptides. 
Approaches using H/De exchange can also be performed by MS with high resolution 
(Zhang et al., 2014). Other common methods for epitope mapping are site-directed 
mutagenesis, or peptide arrays. Site directed mutagenesis involve the replacement of 
amino acids that are considered important for antibody recognition (Liu et al., 2018). 
This way, this technique requires previous knowledge of the interaction profile and is 
considered laborious since every antigen mutant has to be produced individually, 
although advances have been made to turn this option more suitable for high-
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throughput studies (Davidson & Doranz, 2014). In its turn, the peptide array method is 
a good option for defining the epitope with single-amino acid resolution (Vernet et al., 
2015). Nevertheless, besides being an expensive method, since every peptide has to 
be synthetically produced and immobilized on membranes or chips, it may be limited 
to certain kinds of epitopes. To overcome this drawback, some variations of the method 
help on increasing the types of epitopes that can be mapped (Amartely et al., 2014). 
 Considering basic immunology, the epitopes bound by antibodies can be of two 
kinds: “linear” (also called “continuous” or “consecutive”), or conformational (also called 
“discontinuous” or “assembled”). The former is defined as amino acids that are close 
to each other in the sequence and, consequently, in the structure of the antigen. On 
the other hand, conformational epitopes are defined by sequences that are not close 
to each other, but are structurally nearby (Hager-Braun & Tomer, 2005). Works also 
describe information about epitope size, which is often 4-20 amino acids and around 
30 Å in diameter, which results in approximately 700 Å2 contact surface area (Sun et 
al., 2011; Gupta et al., 2013; Rahman et al., 2016). So far, this classification of epitopes 
can explain most of the cases observed, but they appear to be limited to the analysis 
of protein loops only, which are 3D structures that resemble the primary structure of 
proteins. When α-helix or β-sheets are present in the epitope, it becomes more 
complicated to apply these definitions. Considering this, some works have proposed a 
third kind of epitope, called “hybrid” (Opuni et al., 2018). This type involves amino acids 
that are close in sequence, but depend on a secondary structure change to be an 
epitope; thus, they are understood as a mix between “consecutive” and “assembled” 
epitopes. Nevertheless, since antigen structures present much more variability than 
antibodies, it is still complicated to define all possibilities of epitope forms. In this sense, 
research over paratopes and epitopes, especially those involving sequence and 
structure data, is of major importance to increase the knowledge over this field. 
 In a general view, the procedure with biggest resolution for epitope mapping is 
X-ray co-crystallography. However, since this method require special equipment that 
is often not available, other techniques may be used according to what is available to 
the researcher. In many cases, these methods are used in combination either as a way 
to confirm results or to facilitate the use of further techniques (Rojas et al., 2014). In 
either case, phage display shows to be a prominent option. 
 
 28 
 
Interactome phage display 
 Considering that phage display is a technique for protein-protein interaction 
studies, it is possible to analyze proteins that not necessarily compose an antigen-
antibody pair. For this, panning is performed by immobilizing a target antigen and 
incubating it with a library in order to define other antigens that might interact with the 
target (Sundell & Ivarsson, 2014; Blikstad & Ivarsson, 2015). When using an ORFeome 
library (Figure 9A), the output of the panning gives information related to many possible 
proteins that might interact with the studied target (Di Niro et al., 2010). On the other 
hand, the use of single gene library can provide detailed information about the 
interaction partner of the immobilized antigen (Figure 9B). In addition, this approach 
can be used to increase or decrease the affinity of ligands to their receptors by 
generating a library with mutants that are incubated with their reaction partners (Rojas 
et al., 2019). 
 
Figure 9. Use of ORFeome or single gene libraries for protein-protein interaction studies. (A) Use of 
ORFeome libraries against an antigen. The output sequences from this technique indicate candidates 
that may be interaction partners of the immobilized antigen. (B) Use of single gene libraries against an 
antigen. This variation provides information about the specific part of an interaction partner that binds to 
the studied antigen. 
 
Although these approaches are comparable to the previous ones described, it 
is important to highlight that protein-protein interactions may show different affinities 
and behaviors that are harder to deal with when compared to antigen-antibody 
interactions. Considering this difference on obtaining data, this kind of phage display 
is often coupled with next-generation sequencing (NGS) instead of the immunoassay 
screening method (Di Niro et al., 2010). 
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1.2 Listeria spp. biology and its importance in food industry 
The genus Listeria comprises Gram-positive, facultative anaerobic, non-
sporulating, rod-shaped bacteria. After phylogenetic reclassifications, there were 6 
Listeria species described until 2009, from which the last species was described in 
1984 (Seeliger et al., 1984). Later on, 14 new species were described (Graves et al., 
2010; Leclercq et al., 2010; Bertsch et al., 2013; Lang Halter et al., 2013; Núñez-
Montero et al., 2018; Doijad et al., 2018; Leclercq et al., 2019) resulting in a total of 20 
Listeria species: L. monocytogenes, L. ivanovii, L. innocua, L. seeligeri, L. welshimeri, 
L. grayi, L. marthii, L. rocourtiae, L. fleischmannii, L. weihenstephanensis, L. booriae, 
L. newyorkensis, L. floridensis, L. aquatica, L. cornellensis, L. riparia, L. grandensis, L. 
goaenensis, L. costaricensis, and L. thailandensis. This intense description of new 
species in the recent years shows that research over Listeria genus has arising 
importance. Nevertheless, the main relevant pathogen for humans is still L. 
monocytogenes, while L. ivanovii has importance on veterinary medicine (Guillet et al., 
2010). There are 13 different serotypes of L. monocytogenes, from which three (4b, 
1/2a, and 1/2b) are more virulent and responsible for 95-98 % of the human infections 
(Datta & Burall, 2018). 
Listeria genus comprise ubiquitous bacteria, which can be found in many places 
in the environment, as well as in the microbiota of animals and humans. This fact, 
summed to its capacity of forming biofilms, elevated resistance to a broad range of pH 
and temperature, high concentrations of salts, and low amount of oxygen, contributes 
for the presence of this genus in food production facilities (Moorhead & Dykes, 2004; 
Zhang et al., 2011; Cruz & Fletcher, 2011). In addition, due to the complex mechanism 
for gut invasion of L. monocytogenes, it is considered a very important food-borne 
pathogen. The disease caused by these agents is called listeriosis, and affects mostly 
immunocompromised people, such as transplanted, cancer, and HIV patients, as well 
as infants, elderly, pregnant and their fetuses. Even though having low incidence (less 
than 1/100,000 people in most of the countries), the mortality rate worldwide is around 
25 % (Noordhout et al., 2015). Because of this, in countries such as USA, laws 
requiring “zero tolerance” of Listeria in ready-to-eat (RTE) foods are applied (Cruz & 
Fletcher, 2011). In other places, such as in great part of Europe, the laws are less 
strict, allowing up to 100 CFU/g of in RTE foods (EC Regulations, 2005). In other 
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countries, there are either few legislation, comprising certain high-risk foods, or no 
legislation at all, turning Listeria contamination an even bigger concern. Therefore, the 
detection of Listeria in produced food or food production environment is essential. The 
standard method for its detection in food involves microbiological procedures for 
enrichment, isolation, and chemical characterization (Janzten et al., 2006). Although 
very specific and precise, the whole procedure is still time-consuming, taking around 7 
days from sample collection to result. As an alternative, procedures such as PCR-
based techniques, immunological methods, proteomic approaches, and different 
formats of biosensors have been developed in order to reduce the detection time to 
around 1 day or less (Jadhav et al., 2012).  
Among these technologies, antibody-based assays, such as lateral flow tests, 
are considered more interesting, since it offers a simple and low-cost detection. 
Although very attractive for food industry, lateral flow assays, as well as other new 
methods, still depend on an efficient enrichment step prior detection to increase the 
amount of detectable cells in the sample. Recently, some works have described 
significant improvement on the enrichment step, dramatically reducing the time to 
obtain detectable amounts of bacteria (Hahm et al., 2015). However, although works 
have been successfully increasing specificity of the lateral flow through the 
improvement of colorimetric components (Cho et al., 2015), the development of 
appropriate monoclonal antibodies (mAbs) did not advance the same way, leaving 
room for improvement. 
 
1.3 Pathogenic factors of Listeria monocytogenes 
 Listeria monocytogenes is an intracellular pathogen that contains diverse 
mechanisms for invasion, replication, and survival in the host. Once the bacterial cells 
are inside the host, they promote their own cell invasion via proteins presented on their 
surface, such as the internalins A (InlA) and B (InlB) (Pizarro-Cerdá et al., 2012). These 
proteins are able to trigger signals in the host`s cells in order to reorganize the 
cytoskeleton and promote internalization of the bacteria. Even though InlA and InlB 
represent the main factors for cell invasion in L. monocytogenes, other internalins (e.g. 
InlF, InlG and InlH) and proteins such as LAP are also involved, but in a lesser extent 
(Drolia et al., 2018). 
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 Once the bacteria is internalized, it is initially present in a vacuole, isolated from 
the cytoplasm. At this stage, some proteins are activated by the acidic and reductive 
environment of the vacuole, and further act to disrupt the vacuole membrane. The main 
proteins related to this activity are the listeriolysin (LLO), phospholipases (PlcA and 
PlcB), and metalloprotease (MpI), resulting in the release of the bacterial cells to the 
cytosol (Pizarro-Cerdá & Cossart, 2018). Among these proteins, LLO shows to be 
active in many other parts of the host`s cells, having impact on organelles (e.g. 
mitochondria and endoplasmic reticulum) protein metabolism, and DNA stability. When 
the bacterial cells are in the cytoplasm, they possess mechanisms to use metabolites 
from the host in order to have energy. The main factor described for this purpose is the 
hexose phosphate transporter (Hpt), which uptake the glucose-6-phosphate from the 
host`s cells. In addition, the actin assembly-inducing protein (ActA) plays an essential 
role on the motility of L. monocytogenes inside the cells. This protein is responsible to 
capture actin monomers from the host`s cells and build a tail on the bacterial surface 
that promotes its motility. This way, the bacterium is able to avoid intracellular defense 
mechanisms (e.g. autophagosomes), and to promote cell-to-cell spread. Besides these 
mechanisms for invasion and replication of the bacteria, pathogenic factors can also 
be responsible to modulate gene expression of the host`s genes. Proteins such as 
LntA, OrfX, InlC, and even LLO are able to interact with transcriptional factors and 
inhibit responses of the cell against infection. 
 32 
 
 
Figure 10. Process of cell invasion of L. monocytogenes and the main proteins involved. The bacterial 
entry in the host`s cells is mainly triggered by the surface antigens InlA and InlB. Once internalized, 
Listeria cells lyse the vacuole using LLO, PlcA, and PlcB. This way, they can reach the cytoplasm, where 
the bacteria replicated and recruits actin from the invaded cells using ActA. Thereby, Listeria cells gain 
more motility and can spread to adjacent cells, where the process of entry is repeated. This figure is 
adapted from Pizarro-Cerdá et al. (2012).  
 
1.4 Targets for pathogenic and non-pathogenic Listeria detection 
The mostly studied detection targets for Listeria are related to the detection of 
L. monocytogenes, such as the InlA and InlB (Pizarro-Cerdá et al., 2012; Mendonça et 
al., 2012). These proteins are involved in the pathogenesis during the intestinal 
invasion step and are accessible on the cell surface through attachment to the cell wall. 
In addition to these two proteins, others were described for the detection of pathogenic 
species, such as ActA (Nanduri et al., 2007), or N-acetyl muramidase (Bhunia et al., 
1991; Geng et al., 2006). Besides the detection of the pathogenic species, it is also 
important to have information about the presence of non-pathogenic ones. This 
because it has been shown that some non-pathogenic species are able to overgrow 
the pathogenic ones during the enrichment step, increasing the chance of having false-
negative results in detection (Kim & Bhunia, 2008; Oravcová et al., 2008; Besse et al., 
2010). This way, the search of biomarkers for the whole genus, such as p60 (Yu et al., 
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2004), flagellin (Kim et al., 2005), or 1,6-fructose bisphosphate aldolase (FBA) 
(Mendonça et al., 2016), became even more interesting. 
Besides the surface proteins with defined functions, many others started to be 
described to have a previously undefined role in the bacteria. This group of proteins 
that can have more than one function is defined as “moonlighting proteins” (Jeffery, 
2016). In many bacteria, several antigens, usually enzymes, have been described to 
be moonlighting and became more interesting with descriptions of their role in 
pathogenesis (Jeffery, 2018). In L. monocytogenes, the alcohol-acetaldehyde 
dehydrogenase (also named “Listeria adhesion protein”, LAP) is a metabolic enzyme 
that is also involved in the translocation of bacterial cells through the intestinal cells 
(Henderson & Martin, 2011). In addition, the fact that L. monocytogenes is able to 
remodel its surface according to the environment by exposing metabolic enzymes that, 
in principle, should not be located on outer parts of the cell increase the chance of 
having proteins with yet undescribed moonlighting function in this species (Quereda et 
al., 2016). In the field of detection, FBA is an example of protein that should not be 
located on Listeria surface, but is detectable in whole cells when using monoclonal 
antibody (Mendonça et al., 2016). Although not yet described as a moonlighting protein 
in Listeria spp., FBA has been described to have pathogenic role in other 
microorganisms, such as Neisseria meningitidis, Streptococcus pneumoniae, 
Mycobacterium tuberculosis, and Paracoccidioides spp. (Shams et al., 2014).  
 
1.4.1 Pyruvate dehydrogenase complex (PDC) 
The PDC is an enzyme complex that catalyzes the conversion of pyruvate into 
acetyl-CoA, which is a step that connects glycolysis to the citric acid cycle (CAC). Due 
to its crucial role for cellular respiration, this complex is conserved among almost every 
organism, and is composed by three or four different proteins (Patel et al., 2014). 
Although keeping the same function, the structure of the complex and its enzymes vary 
among the different forms of life. In eukaryotes, four enzymes often compose the 
complex, in which a PDC-E3 binding protein (PDC-E3BP) is the additional protein of 
the complex. In prokaryotes, however, the complex is mostly composed of three 
enzymes and presents substantial structural difference between Gram-negative and 
Gram-positive bacteria (Izard et al., 1999). The basic difference between these PDC 
structures lies on the number of PDC-E2 copies that compose the core of the complex. 
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In eukaryotes, there are several models proposed for PDC, which can contain 40-60 
copies of PDC-E2, together with 12-20 of PDC-E3BP. In Gram-negatives, the core is 
composed of ≈24 copies of PDC-E2, while in Gram-positives, the core can also have 
≈24 copies (forming an octahedral symmetry, cube shape) or get closer to that of 
eukaryotes with ≈60 copies (forming an icosahedral symmetry, dodecahedron shape). 
As to the potential moonlighting role of PDC, it may be a case similar to FBA. 
As part of the PDC, the enzyme dihydrolipoamide acetyltransferase (also known as 
pyruvate dehydrogenase complex - enzyme 2, shortly PDC-E2) is responsible for one 
of the reactions in the conversion of pyruvate to acetyl-CoA, which indicates its 
presence in the inner parts of the cell. However, other organisms, such as 
Mycobacterium pneumoniae and Salmonella Enteretidis, show that components of 
PDC can also be involved in pathogenesis (Dallo et al., 2002; Pang et al., 2011). This 
way, it is reasonable that this protein also has its cellular location changed in a way 
similar to what happens with other metabolic proteins, allowing it to be used as a target 
for Listeria spp. detection as will be further discussed in the present document.  
 
1.5 Methods for Listeria detection 
The current “gold-standard” method for Listeria detection in food samples is 
based on enrichment, isolation, and biochemical characterization. However, this 
procedure is considered time-consuming, since it can take up to 7 days for a conclusive 
result, causing a problem for food industry (Janzten et al., 2006). It is possible to 
distinguish two main steps in the detection procedures for Listeria spp. from food: the 
enrichment, and the detection itself (Figure 11). Regarding the former, recent works 
have developed ways to shorten the time needed to acquire detectable amount of 
bacteria from food, reducing it from 16-30 h to 5-8 h (Hahm et al., 2015). In its turn, the 
improvement of the detection part is still topic of investigation. 
 35 
 
 
Figure 11. Scheme of detection strategies for Listeria spp. in food. The detection method for Listeria 
can be defined in two steps: the enrichment, and the detection. The enrichment is based on allowing 
the bacteria present in the food sample to grow until a detectable amount is reached. In its turn, the 
detection can be done directly, as is the case for microbiological methods and immunoassays; or 
indirectly, as it occurs in assays for detecting the DNA, such as PCR or RPA. 
 
Among the different detection methods that can be used as alternative, the 
PCR-based techniques and immunoassays are the most attractive ones for accessing 
the presence of Listeria in food samples (Jadhav et al., 2012). PCR-based techniques 
have the advantage of allowing the detection of low amounts of bacteria, as well as the 
use of different combination of antigens at the same time via multiplex, increasing the 
information over the species present in samples. In addition, this technique can show 
high sensitivity and specificity, reaching a limit-of-detection (LOD) of 10 CFU per gram 
of food (Hahm et al., 2015), or 1 CFU in 25 mL of milk (Moezi et al., 2019). However, 
they are considered expensive and less practical since special equipment and material 
are necessary. 
On the other hand, immunoassays, such as lateral flow, show to be a simpler 
option. This approach do not involve special equipment and presents a much faster 
time to result. Another point is that the LOD is similar to those of other methods, since 
the enrichment step is often providing enough cells to be detected regardless of the 
method used (Jagadeesan et al., 2019). Although presenting relatively good 
performances, there is still interest on improving the diagnostic methods in order to 
reduce their time. Most of the works are focused on the detection part, more specifically 
on the search for new targets and generation of better antibodies that can either reduce 
the amount of bacteria to be detected (i.e. improve the LOD) or increase the diagnostic 
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performance (i.e. specificity and sensitivity). Until today, works report LOD around 106 
CFU/mL (Hahm et al., 2015), which can be improved to 104 CFU/mL by using a 
superparamagnetic lateral flow system (Shi et al., 2015). Other strip tests that do not 
use antibodies, such those employing recombinase polymerase amplification (RPA) or 
nucleic acid lateral flow (Liu et al., 2017; Du et al., 2018; Li et al., 2018), show to be an 
option for improvement, but present similar results as those from previous technologies 
or still have to be further tested in detection with food samples. 
 
In the present work, a combination of three phage display techniques is applied 
for the generation of antibodies, discovery/identification of biomarkers, and 
characterization of antibody-antigen interaction. Using this approach, one target, the 
PDC-E2, was found to allow the detection of every Listeria species tested. In other 
species, this target has already been used as a molecule for therapy, vaccine, or 
diagnostic development (Bryk et al., 2013; Devasundaram & Raja, 2017; Sun et al., 
2014), and also involved in virulence (Pang et al., 2011; Dallo et al., 2002; Wang et al., 
2014). Here, PDC-E2 is described as a target for Listeria spp. detection, which allowed 
to specifically distinguish this genus. The cellular location of the target was accessed, 
as well as its detectability in fluorescent microscopy. In addition, the already known 
targets InlA, InlB, and FBA, as well as two hibridoma-derived antibodies, were 
employed to generate recombinant antibodies for Listeria spp. detection, and to test 
ORFeome and single gene phage display. Finally, the binding region (called “minimal 
sequence of recognition”, shortly MSR) of the generated antibodies was defined in 
order to comprehend the detection profile of the antibodies and target.   
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2 HYPOTHESIS, AIM, AND OBJECTIVES 
  
2.1 Hypothesis 
The combination of different phage display techniques allow finding new targets, 
generating antibodies, and characterizing antigen-antibody interaction in order to 
develop a detection method for Listeria spp.. 
  
2.2 Aim 
Use different phage display technologies to discover, identify, and characterize PDC-
E2 as a new detection target for Listeria spp., and generate antibodies against different 
targets to detect pathogenic and non-pathogenic Listeria. 
  
2.3 Objetives 
 Employ antibody phage display to discover new targets for Listeria spp.; 
 Build ORFeome library for Listeria monocytogenes; 
 Employ ORFeome phage display to identify new targets; 
 Build single gene libraries; 
 Employ single gene phage display to characterize antibody-antigen recognition; 
 Compare different techniques for studying antibody-antigen interaction; 
 Generate recombinant antibodies against already known targets for Listeria 
spp. detection; 
 Test the applicability of generated antibodies in immunoblot and fluorescent 
microscopy; 
 Access the diagnostic performance of the generated antibodies for Listeria spp. 
detection via indirect ELISA. 
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3 MATERIAL AND METHODS 
3.1 Bacteria cultivation and Listeria protein fractionation 
The proteins from cell wall, membrane, and cytoplasm from Listeria spp. cells 
were obtained as described elsewhere (Mishra et al., 2011). Briefly, the strains of L. 
monocytogenes ATCC 7644, and L. innocua DSM 20649 were grown in 200 mL of BHI 
medium at 37 °C until OD600=0.8 from an initial OD600=0.1. The cells were harvested 
by centrifugation (7,000 g; 10 min; 4 °C), suspended in 500 µL of SDS-Tris buffer (0.5% 
SDS; 10 mM Tris; pH 6.9), transferred to a 1.5 mL tube, and incubated 30 min a 37 °C. 
The tubes were centrifuged, and the supernatant containing the cell wall fraction was 
collected. The remaining cell content was mixed with 200 µL of Lysis B solution (100 
mM Tris; 100 mM NaCl; 10 mM MgCl2) and submitted to 3 freeze-thaw cycles at -80 
°C and 37 °C. The tubes were centrifuged (14,000 g; 15 min), and the supernatant 
containing the cytoplasm fraction was collected. The remaining cell content was mixed 
with 200 µL of Sample Solvent buffer (5% SDS, 10% β-mercaptoetanol, 125 mM Tris, 
20% glicerol, pH 6.9) and centrifuged (14,000 g; 20 min) to collect the supernatant 
containing the membrane fraction. 
Each protein fraction was tested by ELISA regarding the presence of the 
proteins InlA (which must be present mainly in the cell wall) and FBA (which must be 
present on every fraction, but mainly in the cytoplasm and membrane). For this, the 
cell wall, cytoplasm, and membrane fractions were diluted in PBS 1:100, 1:100, and 
1:400, respectively, and coated on ELISA Costar plates (Corning). The plates were 
blocked with 2 % MPBS-T (PBS-T with 2 % (w/v) of skimmed milk powder), and 
incubated with monoclonal antibodies 2D12 (anti-InlA, 1 ng/mL) and 3F8 (anti-FBA, 1 
µg/mL). Finally, the plates were incubated either with anti-mouse Fc specific (Sigma), 
for 2D12, or anti-mouse IgA, G, M (Antibodies Online), for 3F8, both HRP conjugated. 
After each step, the wells were washed three times with 300 µL PBS-T. The reaction 
was developed with TMB solution (TMB-A: 50 mM citric acid, 30 mM potassium citrate, 
pH 4.1; TMB-B: 90% (v/v) ethanol, 10% (v/v) acetone; 10 mM tetramethylbenzidine; 1 
mL 30% H2O2; mix 19 parts of TMB-A with 1 part of TMB-B), stopped with 1 N H2SO4, 
and plates were read at 450 nm, using 620 nm as reference. 
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3.2 Expression in E. coli, and purification of the targets InlA, InlB, and FBA 
 The genes for InlA, InlB, and FBA were cloned and described in previous works 
(Mendonça et al., 2012; Braun et al., 1997; Mendonça et al., 2016). Briefly, the 
plasmids pAE-inlA, pET21b-inlB, and pAE-fba were transformed into E. coli BLR(DE3). 
For the expression, the cells containing the respective plasmids were grown in 10 mL 
LB-A for 16 h at 37 °C, 250 RPM. Then, 200 mL of LB-A was inoculated until OD600=0.1 
and grown under the same conditions until OD600=0.6-0.8, when it was induced with 
IPTG to a final concentration of 125 µM and incubated for more 4 h. The cells were 
harvested by centrifugation (10,000 xg; 10 min; 4 °C) and frozen at -20 °C for 16 h. 
Later, the cells were suspended in 20 mL binding buffer (5 mM imidazole, 0.5 M NaCl, 
20 mM Tris-HCl, pH 7.9) before sonication (3x 2 min of pulsed cycles). The suspension 
was centrifuged (16,000 xg; 10 min; 4 °C) and the supernatant transferred to a new 
tube. A SDS-PAGE 12 % and immunoblot with anti-6xHis (Dianova) was performed to 
confirm the expression of the recombinant protein. Finally, the purification was made 
with His-tag purification sepharose (GE Healthcare) in a gravity-flow column using 
washing (60mM imidazole, 0.5M NaCl, 20mM Tris-HCl, pH 7.9) and elution buffers (1M 
imidazole, 0.5M NaCl, 20mM Tris-HCl, pH 7.9). The proteins were dialyzed directly 
against PBS at 4 °C for 16 h, and further checked on SDS-PAGE 12 %, and 
immunoblot anti-6xHis. 
 
3.3 Antibody panning over purified InlA, InlB, and FBA and Listeria protein 
fractions 
For antibody generation against the recombinant proteins, 1 µg of each protein 
was diluted in 150 µL of PBS and coated onto an ELISA Costar plate well overnight at 
4 °C. In parallel, one additional well coated with Panning Block (BSA 1% (w/v), dried 
skim milk 1% (w/v), PBS-T) solution was also made for pre-incubation. The libraries 
HAL9 and HAL10 were mixed for pannings against InlA and InlB, and used separately 
against FBA, always 5x1010 CFU from each. The pre-incubation was done for 30 min 
at RT on a well coated with Panning Block. 
The Listeria protein fractions were used to perform four different panning 
strategies as following: 1) L. monocytogenes ATCC 7644 cell wall fraction, with pre-
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incubations on B. subtilis (1x) and Panning Block (2x); 2) L. monocytogenes ATCC 
7644 cytoplasm fraction, with pre-incubations the same way; 3) L. monocytogenes 
ATCC 7644 membrane fraction, with pre-incubations the same way; 4) same as the 
first strategy, but with a pre-incubation on L. innocua DSM 20649 cell wall in place of 
one of the Panning Block. For each strategy, the according subcellular fractions were 
coated the same way as described in the previous topic, and the pre-incubation was 
made sequentially in three ELISA wells. The first was coated with either heat-
inactivated Bacillus subtilis 168 NCIB 10106 or L. innocua DSM 20649 cell wall. While 
the second and third were coated with Panning Block. The preparation of heat-
inactivated B. subtilis cells was performed by growing the strain in BHI overnight at 37 
°C, 250 RPM. The cells were harvested (2,600 g, 7 min, 4 °C), suspended in 
Carbonate-Bicarbonate buffer until OD600=1.0, and stored at -20 °C until use. Libraries 
HAL9 and HAL10 were used separately the same way as for FBA. 
The remaining panning procedure was done as described elsewhere (Russo et 
al., 2018). Briefly, after transferring the libraries to the wells containing the targets, they 
were incubated 1.5 h at RT, the wells were washed 20x with PBS-T, the bound phage 
was eluted with Trypsin 10 µg/mL and used to infect E. coli TG1 (Lucigen). The infected 
cells were grown at 37 °C up to OD600=0.5, infected with M13K07 phage, and grown 
for 16 h at 30 °C. This procedure was repeated two more times, and on the last time, 
however, the eluted phage were used to infect E. coli XL1-Blue MRF’, which were 
directly plated on 2xYT agar with 100 mM glucose and 100 µg/mL ampicillin (2xYT-
GA) and grown for 16 h at 37 °C.  
The screening of individual clones was also performed by picking colonies from 
the plates of each strategy were pick, which were transferred to 96-well plates 
containing 2xYT-GA and grown for 16 h, at 37 °C, 800 RPM. From these plates, 20 µL 
were transferred to another plates containing 180 µL of the same medium, and grown 
at 37 °C for 1.5 h. Then, the plates were centrifuged (3,200 xg; 10 min; RT), the medium 
was removed, 2xYT-A with 50 µM IPTG was added, and the plates were incubates for 
16 h at 30 °C, 800 RPM. The plates were centrifuged the same way and the 
supernatant was used to perform ELISA against: the respective purified recombinant 
proteins (200 ng/well diluted in PBS) or the Listeria subcellular fractions used for scFv 
selection; live Listeria cells, and live B. subtilis (negative control). The ELISA plates 
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containing the protein fractions were prepared as described on the previous topic. The 
plates containing live cells were prepared by growing L. monocytogenes ATCC 7644, 
as well as L. innocua DSM 20649 and B. subtilis 168 NCIB 10106 in BHI at 37 °C, for 
16 h, 250 RPM. Then, the cells were centrifuged (2,600 xg; 4 °C; 7 min), washed 2 
times with PBS, and suspended in carbonate-bicarbonate buffer 150 mM, pH 9.7, until 
OD600=1.0 (≈ 109 cells/mL). From this solution, 100 µL/well was added on each plate 
for coating for 16 h at 4 °C. Each plate was blocked with 2 % MPBS-T for 30 min, 25 
µL of the E. coli culture supernatants containing the scFv were diluted on 75 µL of 2 % 
MPBS-T into the wells, and incubated 1 h at RT. Later, mouse 9E10 anti-myc-tag IgG 
(1:50), and goat anti-mouse Fc specific HRP-conjugated (1:40,000; Sigma) were 
sequentially added, both diluted in 2 % MPBS-T and incubated for 1 h at RT. After 
each step, the wells were washed three times with 300 µL PBS-T. The reaction was 
developed with TMB solution, stopped with 1 N H2SO4, and the plates were read at 
450 nm, using 620 nm as reference. 
 
3.4 Cloning and production of recombinant antibodies 
The scFv genes selected against purified InlA, InlB, FBA, and subcellular protein 
fractions on the previous step were subcloned into pCSE2.6 vectors with mouse IgG2a 
Fc for scFv-Fc production (Miethe et al., 2014). In the case of GSM133-E2, it was also 
produced as human IgG1 using the vectors pCSEH and pCSL. For this, E. coli XL1-
Blue MRF’ containing the selected phagemids were grown in LB for 16 h at 37 °C and 
used for plasmid extraction with NucleoSpin Plasmid EasyPure kit (Macherey-Nagel). 
After being checked by sequencing, the unique scFv sequences were subcloned to 
pCSE2.6, or to the IgG vectors (using BssHI and NheI for pCSEH, or AgeI and DraIII 
for pCSL), by making digestion of the phagemids with NcoI and NotI (NEB) followed 
by ligation reaction with T4 DNA ligase (Promega) following the manufacturer’s 
instructions. The ligation reaction was used to transform E. coli XL1-Blue MRF’ via heat 
shock and the cells were spread onto 2xYT-GA agar plates for 16 h at 37 °C. The 
resulting colonies on the next day were screened by colony PCR, had their plasmids 
extracted the same way as before, and the possible positive colonies were confirmed 
by sequencing. 
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The resulting pCSE2.6 vectors, or the combination of pCSEH and pCSL, 
containing the scFv-Fc sequences were used to transfect Expi293 HEK cells. The 
transfection is made with polyethylenimine “Max” 40 kDa (Polysciences) using 25 µg 
of PEI with 10 µg of plasmid mixed in 0.5 mL. This volume is then transferred to 5 mL 
of Expi293 HEK cells containing ≈2 × 106 cells/mL. The cells are grown in FreeStyle 
F17 medium (Gibco) supplemented with 8 mM L-glutamine (Biochrom) and 0.1 % 
Pluronic F-68 (PAN-Biotech) for 7 days, and on day 3 they are fed with 5 mL of HEK-
TF and 1 mL of HEK-FS media (Xell). On day 7, the cultures were centrifuged (1,000 
xg, 5 min, RT) and the supernatant used on a 24-well Protein A purification plate 
followed by buffer exchange to PBS using Zeba Spin Desalting 7K columns (Thermo 
Scientific). After purification, the binding of every scFv-Fc on Listeria spp. cells was 
checked by ELISA in a format similar to the one for scFv screening. For that, L. 
monocytogenes, L. innocua, and B. subtilis cells were coated the same way. However, 
the antibodies added were serially diluted √10-fold and incubated 1 h at RT, followed 
by goat anti-mouse Fc specific HRP-conjugated (1:40,000; Sigma) was added, both 
diluted in 2 % MPBS-T. After each step, the wells were washed three times with 300 
µL PBS-T. The reaction was developed with TMB solution, stopped with 1 N H2SO4, 
and the plates were read at 450 nm, using 620 nm as reference. 
 
3.5 Immunoblot and ELISA of scFv-Fc generated against recombinant InlA, 
InlB and FBA 
The immunoblots by running 1 µg of the purified recombinant protein into each 
lane of a 12 % SDS-PAGE gel and subsequently transferred to a methanol-activated 
polyvinylidenfluorid (PVDF) 0.45 µm membrane (Roth). The membrane was blocked 
with 2 % MPBS-T for 16 h at 4 °C, and further incubated with 1 µg/mL of each of the 
scFv-Fc for 1 h at RT. Goat anti-mouse Fc specific HRP-conjugated (1:40,000; Sigma) 
was used as secondary antibody, and DAB solution (6 mg 3.3-diaminobenzidine 
tetrahydrochloride; 10 μL 30 % H2O2; 9 mL PBS; 1 mL NiSO4 250 mM) solution was 
finally added for 15 min. The membrane was washed three times with PBS-T after 
each step. As positive control antibody, a mouse anti-6xHis monoclonal (1:500 in 2 % 
MPBS-T, Dianova) was used. The ELISA was performed by coating 200 ng/well of the 
recombinant target diluted in PBS overnight at 4 °C. After blocking the wells with 2 % 
 43 
 
MPBS-T, each of the produced antibodies were diluted √10-fold 8 times starting with 
10 µg/mL and incubated 1 h at RT. In both assays, goat anti-mouse Fc specific HRP-
conjugated (1:40,000; Sigma) was used as secondary antibody, while SuperSignal 
West Pico (Thermo Scientific) and TMB solution substrates were used for immunoblot 
and ELISA, respectively. 
 
3.6 Immunoblot for target location, immunomagnetic separation, and mass 
spectrometry for target identification 
The produced scFv-Fc against Listeria subcellular protein fractions were used 
for the identification of possible new targets via immunoblot. The protein fractions from 
the cell wall and cytoplasm of L. innocua DSM 20649 were run in a 12 % SDS-PAGE 
and subsequently transferred to a methanol-activated PVDF 0.45 µm membrane 
(Roth). The remaining steps for the immunoblots were done the same way as 
described in the previous topic. 
In order to isolate the target from the protein fractions, immunomagnetic 
separation (IMS) was performed with 100 µL of SureBeads Protein A magnetic beads 
(Bio-Rad), which were coated with 10 µg of each antibody for 10 min at RT. Then, the 
preparation of L. innocua DSM 20649 cytoplasm was diluted 1:2 in PBS in a total of 
200 µL and incubated with the beads for 1 h at RT. Then, the elution was made with 
glycine buffer 20 mM, pH 2.0, for 5 min at RT, to which 10 % (v/v) Na-phosphate buffer 
1 M, pH 7.4, was added. The elution samples were used in 12 % SDS-PAGE, from 
which the proteins referring to the target were excised for further mass spectrometry 
(MS) analysis. The immunoblot was performed the same way as described in the 
previous paragraph, using the same scFv-Fc used for the IMS as primary antibody. 
 
3.7 ORFeome phage display for target identification 
The library used (named L. monocytogenes ATCC 7644) is described in a previous 
work (Mendonça et al., 2016), as well as the panning procedure performed for two 
hibridoma-derived antibodies, 2D12 against InlA (Mendonça et al., 2012) and 3F8 
against FBA (Mendonça et al., 2016). Recombinant antibodies against purified InlA, 
InlB, and FBA were not included. In summary, 2D12 or 3F8 were diluted in Panning 
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Block and coated on two wells of a Costar ELISA plate (Corning, Wiesbaden, 
Germany). Two additional wells were coated with Panning Block only, and the plate 
was incubated for 16 h at 4 °C. The L. monocytogenes ATCC 7644 library (≈1 × 1010 
CFU/mL) was diluted in Panning Block and added to the panning solution well for pre-
incubation for 30 min at RT, while the wells containing the mAbs were blocked with the 
same solution. The library was further transferred to the wells containing the antibody 
and incubated 1.5 h at RT. Then, the wells were washed and eluted with trypsin. The 
eluted phages were used to infect E. coli TG1, which was further infected with 
helperphage M13K07 (MOI 1:20) and grown 16 h at 30 °C, 500 rpm. On the next day, 
the cultures were centrifuged and the supernatant containing phage used instead of 
the library. In total, three panning rounds were done, and the phage eluted after the 
2nd and 3rd rounds were used to infect E. coli XL1-Blue MRF’, which were diluted, plated 
on 2xYT-GA agar plates, and grown for 16 h at 37 °C. The resulting plates were used 
to acquire individual colonies, which were transferred to a 96-well culture plate 
containing 2xYT-GA. The plate was grown for 16 h at 34 °C and then 20 µL was used 
to inoculate another plate with 180 µL/well of the same medium, which was incubated 
2 h at 37 °C. Then, clones in each well were infected with Hyperphage (MOI 1:20) and 
had the medium changed to 2xYT-AK; the plate was then incubated 16 h at 30 °C, 800 
rpm. On the next day, the plate was centrifuged again and the supernatant transferred 
to another plate, in which PEG solution was added and incubated 1 h at 4 °C. The 
plate was centrifuged, the pellet suspended in PBS and centrifuged again. Finally, 50 
µL of each supernatant was added to 50 µL of PBS in a Costar ELISA plate (Corning, 
Wiesbaden, Germany), which was incubated overnight at 4 °C for coating. Afterwards, 
the plate was blocked with 2 % MPBS-T and further incubated with 2D12 or 3F8 
antibody (1 µg/mL) for 1 h at RT. Then, goat anti-mouse IgA, M, G HRP-conjugated 
antibody (AntibodiesOnline, Prod. ABIN376851, 1:4,000) was incubated 1 h at RT. A 
well with anti-M13 (pVIII) HRP-conjugated (1:40,000) served as positive control for 
phage production. The reactions were developed with TMB solution for 15 min and 
read at 450 nm. Reactive clones had their phagemids extracted and sent for 
sequencing. 
As to the recombinant antibodies against subcellular fractions, they were used 
in ORFeome phage display in parallel to MS analysis. The panning procedure was 
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conducted in a similar was as for the hibridoma-derived antibodies with few 
modifications. In this case, 2x1011 CFU of the library was pre-incubated 20 min at RT 
on each of 3 different wells: the first coated with Panning Block; the second coated 
with a non-related scFv-Fc; and the third coated the same way as the second, but with 
additional 10 µg of the non-related scFv-Fc in solution. The remaining steps of panning 
and screening were done the same way as described in the previous paragraph. Only 
one panning round was conducted, and after identifying reactive clones by ELISA, they 
were sequenced and analyzed with BLASTn. In order to confirm and validate the 
results obtained with the screening ELISA, some of the positive hits were produced as 
monoclonal phage in a larger scale. For this, the positive hits were grown in 2xYT-GA 
medium for 16 h at 37 °C. Later, the cultures were inoculated in 5 mL of the same 
medium and grown until OD600≈0.5, when Hyperphage was added to the cultures (MOI 
1:20, ≈1x1010 CFU). They were incubated 30 min at 37 °C, followed by 30 min at 37 
°C, 500 RPM, and transferred to a 100-mL shake flask with 2xYT-AK, which was 
incubated 24 h at 30 °C, 250 RPM. The cultures were centrifuged (16,000 xg; 10 min; 
4 °C), the supernatants transferred to 50-mL tubes and mixed with PEG-NaCl solution 
(20 % (w/v) PEG 6,000; 2.5 M NaCl) to a final concentration of 20 % (v/v), and 
incubated at 4 °C for 1 h. Then, they were centrifuged (3,200 xg; 1 h; 4 °C), the pellet 
containing phage suspended in 500 µL of PBS and transferred to a 2-mL tube, which 
was again centrifuged (16,000 xg; 1 min; RT), and the liquid transferred to a new tube. 
This solution containing the produced phage was titrated by infecting E. coli XL1-Blue 
MRF’ at OD600≈0.5 in different dilutions. The produced monoclonal phage were then 
used in indirect ELISA to confirm the binding of each antibody. For this, different 
amounts of phage were coated onto ELISA wells, starting with 109 CFU/well and 
diluting 8 times √10-fold. Then, each antibody against the respective monoclonal 
phage was used diluted in 2 % MPBS-T to 2 µg/mL, and incubated 1 h at RT. The, 
goat anti-mouse Fc specific HRP-conjugated (1:40,000; Sigma) was added, followed 
by TMB solution and 1 N H2SO4, as described in previous paragraphs. After each step, 
the wells were washed three times with 300 µL PBS-T, and plates were read at 450 
nm, using 620 nm as reference. 
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3.8 Immunofluorescence and wide field fluorescent microscopy of Listeria 
cells 
The strain L. monocytogenes ser. 4b DSM 15675 was grown in BHI (16 h; 37 
°C, 110 RPM), 2 mL were centrifuged (2,500 xg; 2 min), washed 2 times with PBS, and 
incubated with three different antibodies: 1) GSM29-D3 scFv-Fc (anti-internalin A) as 
positive control; 2) a non-related scFv-Fc as negative control; and 3) GSM133-A4 
scFv-Fc (anti-PDC-E2, as experiment molecule). These antibodies were diluted in 2 % 
MPBS-T to 5 µg/mL and incubated 1 h at RT. The cells were then washed three times 
with PBS-T and incubated 1 h at RT with anti-mouse Alexa 647 secondary antibody 
(Thermo Scientific), diluted 1:500 in 2 % MPBS-T. The cells were washed the same 
way and suspended in a corresponding volume of DAPCO (1,4-
diazabicyclo[2,2,2]octane) containing mounting medium. Sample preparation was 
performed as described before (Boedeker et al., 2017). Briefly, 2 µL of the suspension 
were added to 1 % (w/v) agarose pads to reduce cell movement, which were 
surrounded with grease (Vaseline, Lenhart Kosmetik) and covered with high-precision 
coverslip (LH24.1, Roth). Imaging was performed with a Nikon Eclipse Ti inverse 
microscope with Fm4–64 (650/13-705/72) filters. Fluorescence z-stacks and bright-
field images were taken using a Nikon N Plan Apochromat l λx100/1.45 oil objective 
and the ORCA FLASH 4.0 HAMMATSU camera. Images were processed using the 
NIS-elements imaging software V4.3 (Nikon) together with the 3D Landweber 
Deconvolution algorithm. 
 
3.9 Cloning, expression in E. coli, and purification of the recombinant target 
PDC-E2 
The gene (AL596167.1:98629-100260) and protein (WP_010990728.1) 
sequences were obtained from GenBank and used to design primers for the 
subcloning. Primers containing the restriction sites NdeI and NotI were ordered as 
following: forward 5’-AATTCCATATGGCATATTCATTTAAATTACCGGATATCG-3’, 
and reverse 5’-ATTGCGGCCGCCACCTCCATTAGTAATAATTCTG-3'. The PCR was 
conducted with Phusion High-Fidelity DNA Polymerase (Thermo Scientific), according 
to the manufacturer’s instructions, and using the genomic DNA of L. monocytogenes 
ATCC 7644 as template with the following thermocycler program: 98 °C, 30 s + 98 °C, 
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10 s; 56.5 °C, 30 s; 72 °C, 40 s (x30) + 72 °C, 5 min. The amplified gene was checked 
in an agarose gel 0.8 % and digested with NdeI and NotI (NEB), as well as the 
expression vector pET21a(+) (Novagen). Then, a T4 DNA Ligase (Promega) was 
performed and used to transform E. coli XL1-Blue MRF’ via heat shock. The cells were 
spread onto a 2xYT-GA agar plate and grown at 37 °C for 16 h. Recombinant clones 
were screened by PCR and confirmed by sequencing. One correct clone was 
propagated and used to obtain plasmid to transform the expression strain E. coli 
BLR(DE3) also via heat shock.  
For the expression, the same procedure made for InlA, InlB and FBA was 
performed. Briefly, E. coli BLR(DE3) containing pET21a(+)/PDC-E2 was grown LB-A, 
transferred to 200 mL of of the same medium until OD600=0.1 and grown under the 
same conditions until OD600=0.6-0.8, when it was induced with IPTG and incubated for 
more 4 h. The cells were harvested and frozen at -20 °C for 16 h, suspended in 20 mL 
binding buffer and sonicated before sonication. The suspension was centrifuged and 
the supernatant transferred to a new tube. Analysis with SDS-PAGE 12 % and 
immunoblot, as well as the purification were done the same way as before. The dialysis 
was made against elution buffer diluted with PBS to gradually decrease the 
concentration of NaCl (reduction of 50 mM every 1-2h), followed by a dialysis against 
only PBS (Moreira et al., 2016). 
 
3.10 Antibody panning over recombinant PDC-E2 
For antibody generation against recombinant PDC-E2, the same procedure 
made for InlA and InlB was done. Briefly, 1 µg of the protein was diluted in 150 µL of 
PBS and coated onto an ELISA Costar plate well overnight at 4 °C. In parallel, one 
additional well coated with Panning Block solution was also made for pre-incubation. 
Libraries HAL9 and HAL10 were mixed in the same panning well and three rounds 
were performed. The screening of the scFv was also performed the same way, using 
L. monocytogenes ATCC 7644, as well as L. innocua DSM 20649 and B. subtilis 168 
NCIB 10106. A plate coated with 200 ng/well of the recombinant protein diluted in PBS 
was prepared as positive control. 
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3.11 Indirect ELISA for Listeria spp. detection 
The employed strains (Tables 1 and 2) were from the German Collection of 
Microorganisms and Cell Cultures (“Leibniz-Institut DSMZ, Deutsche Sammlung von 
Mikroorganismen und Zellkulturen”). Each bacterium was recovered from lyophilized 
stocks with BHI, grown in 10 mL BHI, and streaked onto BHI-agar plates. The 
exception was L. paracasei, which was always grown in MRS or MRS-agar. The 
bacteria were grown at 30 or 37 °C according to their need, under 110 or 80 RPM, 
respectively. When needed, microaerobic condition was created with the use candle 
jars. 
For the ELISA, a single colony of each bacteria was taken from the plates and 
grown in 10 mL of the corresponding medium, and under the described conditions. As 
previously described in this work, all cells were centrifuged, washed twice with PBS, 
and suspended in carbonate-bicarbonate buffer until OD600=1.0. Then, ELISA plates 
were prepared by coating 100 µL/well of the cell suspension 16 h at 4 °C. Plates were 
blocked with 2 % MPBS-T for 1 h at RT, and further incubated 1 h at RT with the 
different antibodies diluted in 2 % MPBS-T in three different concentrations: a) the 
estimated EC50 (named “EC50”); b) a √10 dilution above the EC50 (named “EC50+”); and 
c) a √10 dilution below the EC50 (named “EC50-”). Then, goat anti-mouse IgG Fc 
specific HRP-conjugated (1:30,000; Jackson ImmunoResearch Laboratories) was 
diluted in 2 % MPBS-T and incubated 1 h at RT. As controls, wells with a non-related 
scFv-Fc, diluted √10-fold starting with 10 µL/mL, and only the secondary antibody were 
used. After each step, the wells were washed two times with 300 µL PBS-T. The 
reaction was developed with TMB solution, stopped with 1 N H2SO4, and the plates 
were read at 450 nm, using 620 nm as reference. Every combination of antibody 
concentration and bacterial strain was performed in a single well that was repeated 
twice in independent plates. Thus, only one of the repetitions was selected to perform 
the statistical analysis. 
To determine the diagnostic value for each antibody, a signal-to-noise ratio was 
calculated with every read divided by the average of three wells from the secondary 
antibody control of each plate. The resulting values for each antibody dilution and 
bacterial strain combination were used in a Receiver Operating Characteristic (ROC) 
analysis using GraphPad software (Prism, v 5.01), in which the sensitivity and 
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specificity, as well as the confidence intervals (CI), was calculated. To facilitate 
description of these results, the area under the ROC curve (AUC) value was also used 
for representing this data instead of the ROC curve itself. 
 
Table 1. List of the Listeria species used for indirect ELISA. 
Species Serovar DSM nº Temperature (°C)/condition 
L. monocytogenes 4b 15675 37/aerobic 
 1/2a 102976 37/aerobic 
 1/2b 19094 37/aerobic 
L. innocua 6a 20649 37/aerobic 
L. marthii NI 23813 37/aerobic 
L. welshimeri 1/2b 20650 37/aerobic 
L. ivanovii 5 20750 37/aerobic 
L. seeligeri 1/2b 20751 37/aerobic 
L. floridensis NI 26687 37/aerobic 
L. fleischmannii 
subsp. fleischmannii 
NI 24998 37/aerobic 
L. aquatica NI 26686 37/aerobic 
L. grayi NI 20601 37/aerobic 
L. cornellensis NI 26689 30/aerobic 
L. rocourtiae NI 22097 30/aerobic 
L. booriae NI 28860 37/aerobic 
L. riparia NI 26685 37/aerobic 
L. 
weihenstephanensis 
NI 24698 30/aerobic 
L. grandensis NI 26688 30/aerobic 
L. newyorkensis NI 28861 37/aerobic 
NI, not informed. 
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Table 2. List of the non-Listeria species used for indirect ELISA. 
Species Serovar DSM nº Temperature (°C)/condition 
Salmonella enterica Typhimurium 17058 37/aerobic 
Escherichia coli O157:H7 17076 37/aerobic 
Pseudomonas 
aeruginosa 
NI 50071 37/aerobic 
Klebsiella pneumoniae 3 30104 37/aerobic 
K. aerogenes NI 30053 30/aerobic 
Enterobacter cloacae NI 30054 30/aerobic 
Staphylococcus aureus 3 20231 37/aerobic 
Jonesia denitrificans NI 20603 37/aerobic 
Bacillus subtilis NI 10 30/aerobic 
B. thuringiensis NI 2046 30/aerobic 
B. cereus NI 31 30/aerobic 
Enterococcus faecium D, 11 20477 37/microaerobic 
E. faecalis D 20478 37/microaerobic 
E. lactis NI 23655 37/microaerobic 
Lactococcus lactis N 20481 30/microaerobic 
Lactobacillus paracasei NI 5622 30/microaerobic 
NI, not informed. 
 
3.12 Single gene phage display for identifying the binding region of hibridoma-
derived antibodies against InlA and FBA, and scFv-Fc against PDC-E2 
A single gene library was built with the genes coding for InlA, FBA, and PDC-
E2 following procedures already described (Moreira et al., 2018; Fühner et al., 2019). 
Briefly, the gene was amplified via PCR with Phusion DNA polymerase (Thermo 
Scientific), fragmented with sonication using Bioruptor Plus (Diagenode), and cloned 
into pHORF3 phagemid after DNA end repair reaction with Fast DNA End Repair 
(Thermo Scientific). After ligation with T4 DNA ligase (Promega), the reaction product 
was purified with Ultracel-0.5 mL Ultracel-30K columns (Amicon) and used to transform 
E. coli SS320 (Lucigen) via electroporation. The transformed cells were spread onto 
2xYT-GA agar 25-cm plates, and onto 10-cm plates for titration and library checking. 
Some colonies were picked from the latter plates and amplified via colony PCR to 
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check the insert rate of the ligation. While from the former plate, the cells were taken 
and used to perform library packaging with Hyperphage. For this, the bacteria were 
scraped out of the plates with 2xYT-GA, grown until OD600=0.5, and infected with 
Hyperphage. After growing for 24 h at 30 °C, the packaged library was precipitated 
from the supernatant with PEG/NaCl solution and titrated using E. coli XL1-Blue MRF’. 
From the titration plates, some clones were sent for sequencing to check the in-frame 
rate of the library. 
The panning was performed in a way similar to the ORFeome panning for target 
identification. Briefly, 1 µg of each antibody was coated on a well of and ELISA plate, 
and the pre-incubation with three wells was done the same way. In this case, 109 CFU 
were used per panning well, and only the first panning round was conducted. The 
screening was done the same way, once reactive clones were sent for sequencing and 
the resulting sequences were aligned with ClustalOmega software to define the 
minimal sequence of recognition (MSR, defined as the shortest sequence present on 
every clone sent for sequencing).  
 
3.13 Sequence analysis of PDC-E2 and FBA 
The protein sequences of the target PDC-E2 detected with MS and ORFeome 
phage display, as well as of the FBA (Mendonça et al., 2016), were compared to 
sequences of the related protein from the species used in the indirect ELISA (Table 3 
and Table 4). The identity and similarity were calculated with the online tool EMBOSS 
Needle (Li et al., 2015). The sequence of PDC-E2 (GenBank code: WP_107899613.1) 
was also analyzed with SMART online software (Letunic & Bork, 2018), which allowed 
defining the different regions of the protein. 
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Table 3. GenBank codes, identity and similarity of the PDC-E2 sequences from the organisms used in 
indirect ELISA. 
Organism GenBank code Identity 
(%) 
Similarity 
(%) 
Gaps (%) 
Listeria 
monocytogenesa,* 
WP_107899613.1 100.0 100.0 None 
L. innocua b WP_010990728.1 99.3 99.4 None 
L. marthiic EFR88158.1 98.2 98.9 None 
L. welshimeri WP_011701854.1 98.2 98.7 None 
L. ivanovii WP_014092472.1 97.1 98.2 None 
L. seeligeri WP_012985326.1 96.1 97.6 None 
L. floridensis WP_036096782.1 83.2 89.6 1.8 
L. fleischmannii subsp. 
fleischmannii 
WP_007472784.1 83.0 89.4 2.7 
L. aquatica WP_036071619.1 82.7 89.6 2.6 
L. grayi WP_036106310.1 82.4 88.5 2.2 
L. cornellensis WP_036077440.1 82.0 89.5 2.5 
L. rocourtiae WP_036070034.1 82.0 89.3 2.2 
L. booriae WP_036086614.1 81.9 89.5 3.2 
L. riparia WP_036098974.1 81.9 89.5 3.2 
L. weihenstephanensis WP_036063351.1 81.9 89.3 2.9 
L. grandensis WP_036067464.1 81.9 89.1 2.9 
L. newyorkensis WP_059140683.1 81.9 88.9 2.9 
     
Salmonella enterica WP_073877127.1 36.3 54.7 10.6 
Escherichia coli WP_057699170.1 35.4 53.3 11.1 
Pseudomonas 
aeruginosa 
WP_042930711.1 35.0 53.5 6.9 
Klebsiella pneumoniae KMH79087.1 34.6 53.4 10.6 
K. aerogenes WP_058655303.1 34.9 52.9 10.6 
Enterobacter cloacae WP_023480469.1 30.7 47.2 21.4 
     
Staphylococcus 
aureusd 
WP_061644423.1 51.8 60.8 24.8 
Enterococcus faecalis WP_010827359.1 62.9 73.9 5.2 
E. faecium WP_104674310.1 60.7 73.2 5.2 
E. lactis NF NF NF NF 
Lactobacillus paracasei WP_003598571.1 55.7 70.7 6.6 
Bacillus cereus WP_078181369.1 52.3 62.6 23.4 
B. thuringiensis WP_000863429.1 51.7 63.3 23.4 
B. subtilis WP_060398546.1 50.4 61.9 24.6 
Lactococcus lactis WP_011675116.1 44.4 62.1 4.7 
Jonesia denitrificans WP_015772709.1 26.3 39.7 30.9 
a Sequence found with MS. 
b Sequence found via ORFeome phage display followed by BLASp. 
c Sequence is “partial”. 
d S. aureus was not included in the indirect ELISA experiments due to protein A-related background on 
every well. 
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NF, not found with BLASTp. 
* L. monocytogenes sequence was used as reference in the alignment. 
 
Table 4. GenBank codes, identity and similarity of the PDC-E2 sequences from the non-Listeria 
organisms used in indirect ELISA. 
Organism GenBank code Identity 
(%) 
Similarity 
(%) 
Gaps (%) 
Listeria 
monocytogenes 
WP_003729264.1 100.0 100.0 None 
     
Salmonella enterica WP_023200272.1 40.1 57.5 2.1 
Escherichia coli WP_053287829.1 52.1 70.5 1.7 
Pseudomonas 
aeruginosa 
WP_065278711.1 32.5 49.0 21.3 
Klebsiella pneumoniae WP_115196261.1 51.6 67.2 1.4 
K. aerogenes WP_023312727.1 50.9 66.9 1.4 
Enterobacter cloacae WP_063624399.1 42.2 58.8 6.1 
     
Staphylococcus aureus 
a 
WP_001662541.1 65.6 78.6 0.4 
Enterococcus faecalis WP_010818782.1 51.5 68.4 3.1 
E. faecium WP_002345564.1 50.9 68.4 3.1 
E. lactis NF --- --- --- 
Lactobacillus paracasei WP_128538748.1 47.1 64.6 2.7 
Bacillus cereus WP_098682829.1 70.2 80.7 0.4 
B. thuringiensis WP_042969964.1 70.2 80.7 0.4 
B. subtilis WP_014481411.1 60.7 74.5 2.1 
Lactococcus lactis WP_075525349.1 48.0 65.7 6.0 
Jonesia denitrificans WP_015772663.1 28.8 44.4 22.2 
a S. aureus was not included in the indirect ELISA experiments due to protein A-related background on 
every well. 
NF, not found with BLASTp. 
* L. monocytogenes sequence was used as reference in the alignment. 
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4 RESULTS 
4.1 Antibody panning over Listeria protein fractions provides useful binders 
for detection 
Antibodies were generated against Listeria protein fractions by phage display 
and, after screening of monoclonal binders, four scFv-Fc were validated by titration 
ELISA over alive bacterial cells (Fig. 1). These four antibodies allowed the detection of 
both pathogenic (L. monocytogenes) and non-pathogenic (L. innocua) species of 
Listeria, while showing practically no reaction with the non-related species B. subtilis. 
Even though just a small number of strains was used, it is possible to affirm that the 
target is accessible on the surface of the coated cells.  
 
Figure 12. ELISA of the scFv-Fc antibodies generated against Listeria protein fractions. The monoclonal 
scFv-Fc GSM133-A4 (A), GSM130-H1 (B), GSM133-E2 (C), and GSM134-C1 (D) were diluted √10-fold 
from 10 µg/mL until 3.2 ng/mL. Then, they were tested against three strains coated alive onto ELISA 
plates: L. monocytogenes ATCC 7644 (L. mono), L. innocua DSM 20649 (L. innocua), and B. subtilis 
168 NCIB 10106 (B. subtilis). 
In addition to the ELISA, these initial four antibodies were tested in immunoblot 
against cell wall and cytoplasm fractions of L. innocua. The results indicate that the 
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target protein is present on both fractions with apparent more concentration in the 
cytoplasm (Figure 13). This way, it was possible to explain the ELISA results, in which 
alive cells were detected when coated on a plate, indicating its actual location on the 
cell surface. Although the EC50 could not be precisely determined, GSM133-A4 
showed the best binding, since the highest dilution presented about 2-fold higher signal 
when compared to the other antibodies. Thus, this antibody was chosen for further 
initial characterization of the target. 
 
Figure 13. Immunoblot of the scFv-Fc antibodies generated against Listeria protein fractions. The 
monoclonal scFv-Fc GSM133-A4, GSM130-H1, GSM133-E2, and GSM134-C1 were diluted and tested 
against protein fractions from cell wall and cytoplasm of L. innocua DSM 33090 (Linn). The strain E. coli 
BLR(DE3) was used as negative control. 
 
4.2 ORFeome phage display provides similar results to those from mass 
spectrometry regarding target identification 
After generating antibodies against protein mixtures of Listeria, the target was 
identified by either IMS-MS and ORFeome phage display. In order to have samples 
suitable to MS, IMS was made using GSM133-A4 to isolate the target from the 
cytoplasmic protein mixture. This procedure led to the proper isolation of the target, as 
confirmed by SDS-PAGE and immunoblot (Fig. 2A). In addition to the target, other 
proteins (named as “unknown” 1-3) were also detected in SDS-PAGE. This way, all 
proteins were cut from the gel and analyzed by MS, which identified the protein 
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dihydrolipoamide acetyltransferase (GenBank: WP_010990728.1), also known as 
pyruvate dehydrogenase complex - enzyme 2 (PDC-E2), as the target. While the 
unknown proteins 2 and 3 were detected as PDC-E1α (GenBank: WP_072572643.1) 
and PDC-E1β (GenBank: WP_038409535.1). Considering this information, it is 
possible to assume that the “unknown 1” protein would refer to PDC-E3, meaning that 
the whole complex was captured in the procedure, but it was not properly detected due 
to its close proximity with the scFv-Fc. The MS analysis was done in by the Proteomics 
group of Helmholtz-Zentrum für Infektionsforschung (HZI) under the supervision of 
Prof. Dr. Lothar Jänsch. 
In parallel to the MS analysis, ORFeome phage display was performed to 
identify the target of the four initial antibodies (GSM130-H1, 133-A4, 133-E2, and 134-
C1) using an antigen library built with the genome of L. monocytogenes ATCC 7644. 
With this approach, the identified target was also PDC-E2 (GenBank: 
WP_107899613.1, Table 5). Out of the four antibodies used, only GSM134-C1 did not 
allow to identify the target (Fig. 2B). Moreover, the panning with GSM133-A4 resulted 
in two hits: one referring to PDC-E2, and another to a non-related protein that was 
discarded due to low reactivity (data not shown). 
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Table 5. Summary of the hits found by mass spectrometry or ORFeome phage display. 
Technique Antibody 
used 
GenBank code Protein information a 
Mass 
spectrometry 
GSM133-A4 WP_010990728.1 dihydrolipoamide 
acetyltransferase, Listeria innocua 
(target) 
  WP_072572643.1 pyruvate dehydrogenase (acetyl-
transferring) E1 component 
subunit alpha, Listeria 
monocytogenes (unknown 2) 
  WP_038409535.1 alpha-ketoacid dehydrogenase 
subunit beta, Listeria 
monocytogenes (unknown 3) 
ORFeome 
phage 
display 
GSM130-H1, 
GSM133-A4, 
GSM133-E2 
WP_107899613.1 b dihydrolipoamide 
acetyltransferase, Listeria 
monocytogenes 
a For mass spectrometry, the protein information also contain the protein identification used in Figure 3 
of the main article in parenthesis. For ORFeome phage display, the antibody used for target 
identification, also shown in Figure 3, is in parenthesis. 
b This code refers to the cloned sequence used in further steps, which was present in the BLASTx 
results of the output sequences for the mentioned antibodies. 
 
To confirm that the isolated antigen fragments were actual correct targets, some 
were produced as monoclonal phage and tested by ELISA against the respective 
antibodies. This showed that every antibody-peptide phage combination was correct, 
presenting higher reactions then the negative control in a concentration-dependent 
way (Fig. 2C). In addition, since the isolated fragments of the 3 antibodies are close 
related to each other in the protein sequence, some were tested with GSM134-C1, 
which did not select any fragment on panning. The result showed that this scFv-Fc can 
recognize the peptides isolated from panning with other antibodies, indicating that it 
may bind to a similar region. Furthermore, it is important to mention that the reactions 
of GSM133-E2 was lower than other antibodies, indicating a different behavior of this 
scFv-Fc. 
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Figure 14. Identification of the target via MS and ORFeome phage display. (A) SDS-PAGE and 
immunoblot after IMS with GSM133-A4. (B) Alignment of the first 209 amino acids of a reference PDC-
E2 sequence (WP_107899613.1) with the MSR of scFv-Fc GSM130-H1, GSM133-A4, and GSM133-
E2 after ORFeome phage display. (C) Titration curves of the 4 initial scFv-Fc against different amounts 
of monoclonal phage isolated in the ORFeome phage display for target identification. 
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4.3 PDC-E2 target is detectable by fluorescent microscopy, giving more 
evidence for its location on bacterial cell surface 
In order to check the accessibility of PDC-E2 on the bacterial surface and the 
ability of the PDC-E2 target in being recognized by antibodies in microscopy, GSM133-
A4 was also employed to stain L. monocytogenes ser. 4b DSM 15675 in fluorescence 
microscopy (Fig. 3B). The negative control with a non-related scFv-Fc shows 
imperceptible fluorescence in Cy5 channel. On the other hand, the positive control 
using a scFv-Fc anti-InlA, which is a well-characterized target that is linked to the cell 
wall and displayed on the surface of L. monocytogenes, showed better visible 
fluorescence. In its turn, the Cy5 fluorescence of GSM133-A4 showed to be much 
clearer, demonstrating that the target is actually accessible on Listeria cell surface and 
likely laying on Listeria cell wall. This procedure was done together with Dr. Christian 
Boedeker in DSMZ. 
 
Figure 15. Fluorescence microscopy of GSM29-D3 (anti InlA) and GSM133-A4 (anti PDC-E2) over alive 
L. monocytogenes 4b DSM 15675. When comparing the signals of both scFv-Fc with those from the 
negative control with a non-related antibody, it is possible to confirm that they are applicable for 
fluorescent microscopy. Moreover, the experiment indicates that the target of GSM133-A4 is accessible 
on Listeria cell surface, more likely laying on the cell wall. 
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4.4 Antibody panning over purified recombinant PDC-E2 increases the 
number of generated binders 
In order to increase the set of antibodies against PDC-E2, a second antibody 
panning was performed, this time, over the recombinant protein. For this, PDC-E2 
gene was cloned and expressed as a recombinant protein in E. coli. Then, the purified 
protein was used to select antibodies from HAL9 and HAL10 libraries, which were now 
mixed in the same panning well. With this approach, other 16 binders were identified 
and produced as scFv-Fc. Initial tests showed that they bind specifically to Listeria spp. 
when using 4 strains for an initial screening and are all able to recognize recombinant 
PDC-E2 in immunoblot and ELISA (Fig. 4 and Fig. 5). This way, antibody panning over 
the purified antigen could increase the number of useful binders, allowing the 
generation of approximately 4 times more antibodies when compared to the panning 
on subcellular fractions. 
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Figure 16. Immunoblot of the scFv-Fc antibodies generated against the purified recombinant PDC-E2. 
The 20 newly generated scFv-Fc were diluted to 1 µg/mL and tested against 1 µg of the recombinant 
PDC-E2. 
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Figure 5 continues on the next page. 
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Figure 17. ELISA of the scFv-Fc antibodies generated against the purified recombinant PDC-E2. The 
20 newly generated scFv-Fc (A-T) were diluted √10-fold from 10 µg/mL until 3.2 ng/mL. Then, they were 
tested against the recombinant PDC-E2 (rE2 target) and three strains coated alive onto ELISA plates: 
L. monocytogenes ATCC 7644 (L. mono), L. innocua DSM 20649 (L. innocua), and B. subtilis 168 NCIB 
10106 (B. subtilis). 
 
4.5 PDC-E2 target allows the detection of every Listeria spp. via indirect ELISA 
In total, 20 scFv-Fc against PDC-E2 were used in indirect ELISA for Listeria 
spp. detection. When performing the ROC analysis, the concentrations showing the 
best AUC were used to estimate the best equilibrium of sensitivity and specificity. Out 
of this antibody set, two scFv-Fc (GSM313-E9, and GSM313-H8) showed to 
discriminate Listeria spp. from other tested species with 100 % sensitivity and 
specificity, with AUC=1.0 (Table 6). Thus, these two were considered the most suitable 
for detection. The next three antibodies with best performance are GSM313-F5, 
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GSM313-G12, and GSM130-H1, from which it is interesting to observe that GSM130-
H1 is the only one derived from the panning over Listeria protein fractions. 
 
Table 6. Diagnostic performance of all the scFv-Fc targeting PDC-E2. 
Antibody Best 
concentration 
a 
Sensitivity % 
(CI) 
Specificity % 
(CI) 
AUC (CI) 
GSM313-E9 EC50+ 100.0 (82.35-
100.0) 
100.0 (78.20-
100.0) 
1.0 (1.0) 
GSM313-H8 EC50+ 100.0 (82.35-
100.0) 
100.0 (78.20-
100.0) 
1.0 (1.0) 
GSM313-F5 EC50+ 94.74 (73.97-
99.87) 
100.0 (78.20-
100.0) 
0.993 (0.9746-
1.011) 
GSM313-G5 EC50- 100.0 (82.35-
100.0) 
93.33 (68.05-
99.83) 
0.993 (0.9745-
1.011) 
GSM130-H1 EC50+ 94.74 (73.97-
99.87) 
93.33 (68.05-
99.83) 
0.9895 (0.9663-
1.013) 
GSM313-G12 EC50+ 89.47 (66.86-
98.70) 
100.0 (78.20-
100.0) 
0.986 (0.9574-
1.014) 
GSM313-D10 EC50+ 94.74 (73.97-
99.87) 
93.33 (68.05-
99.83) 
0.9789 (0.939-
1.019) 
GSM313-C9 EC50+ 89.47 (66.86-
98.70) 
100.0 (78.20-
100.0) 
0.9579 (0.8904-
1.025) 
GSM313-D6 EC50 84.21 (60.42-
96.62) 
100.0 (78.20-
100.0) 
0.9439 (0.8705-
1.017) 
GSM313-G11 EC50+ 89.47 (66.86-
98.70) 
86.67 (59.54-
98.34) 
0.9439 (0.8693-
1.018) 
GSM313-B1 EC50- 100.0 (82.35-
100.0) 
80.0 (51.91-
95.67) 
0.9404 (0.8646-
1.016) 
GSM134-C1 EC50- 94.74 (73.97-
99.87) 
80.0 (51.91-
95.67) 
0.8965 (0.7803-
1.013) 
GSM133-A4 EC50 94.74 (73.97-
99.87) 
80.0 (51.91-
95.67) 
0.8947 (0.7815-
1.008) 
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GSM313-H11 EC50+ 89.47 (66.86-
98.70) 
86.67 (59.54-
98.34) 
0.8596 (0.7135-
1.006) 
GSM313-E1 EC50+ 94.74 (73.97-
99.87) 
80.0 (51.91-
95.67) 
0.8246 (0.6465-
1.003) 
GSM313-F7 EC50 73.68 (48.80-
90.85) 
73.33 (44.90-
92.21) 
0.7895 (0.618-
0.9609) 
GSM133-E2 EC50- 78.95 (54.43-
93.95) 
73.33 (44.90-
92.21) 
0.7789 (0.5889-
0.969) 
GSM313-B12 EC50+ 73.68 (48.80-
90.85) 
66.67 (38.38-
88.18) 
0.7789 (0.6205-
0.9374) 
GSM313-F10 EC50+ 94.74 (73.97-
99.87) 
66.67 (38.38-
88.18)  
0.7158 (0.5034-
0.9282) 
GSM313-G10 EC50- 63.16 (38.36-
83.71) 
66.67 (38.38-
88.18) 
0.6632 (0.4727-
0.8536) 
a As mentioned in the material and methods section, the antibody concentrations used were: the EC50; 
a √10-fold concentration above the EC50 (EC50+); and a √10-fold concentration below (EC50-). 
When analyzing the reaction of the antibodies against the tested strains, it is 
possible to observe some important aspects of recognition. One of them is that the 
species L. aquatica, L. grayi, and L. cornellensis were difficult to be recognized, since 
11, 8, and 7, respectively, out of the 20 antibodies were not able to detect these species 
(Fig. 6). Other important observation is that most of the reactions with non-Listeria 
species were against Enterococcus (11/20) and Bacillus (8/20) genus, sometimes with 
more than one species of each. This fact may imply that the recognition of these 
antibodies are not unspecific, but undesired, since it appears that Gram-positives may 
have a preference on the recognition of PDC-E2. In accordance to this, PDC-E2 
sequences from both Enterococcus and Bacillus are the ones showing to be closer 
related to the one from L. monocytogenes, around 50-60 % identity, while the other 
strains, except L. paracasei (55.7 %), did not surpass 45 % (Table 3). 
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Figure 18. Reaction profile of the 20 antibodies targeting PDC-E2 in indirect ELISA. Indirect ELISA was 
done with 19 Listeria strains (dark blue background) and 15 non-Listeria strains, including Gram-
negative (golden background) and Gram-positive (light blue background). After performing a ROC curve 
analysis, the cut-off value for each antibody was used to determine positive (green) and negative (red) 
reactions. 
 
4.6 Most of the generated antibodies against PDC-E2 recognize the lipoyl 
domains (LD) 
To further analyze the anti-PDC-E2 antibodies, their MSR was determined with 
single-gene phage display using a library displaying fragments of PDC-E2. This way, 
the 18 of the 20 antibodies used for the indirect ELISA had their binding region defined. 
Interestingly, all but one of the mapped antibodies showed to bind the same region, 
which was either the 1st or 2nd LD (Table 7). Besides this, some cases are worth to be 
mentioned. One is that 4 out of 18 antibodies (GSM133-A4, GSM313-D10, -F7, and -
G10) are able to recognize both LD domains, although one is preferred. Another case 
is with GSM133-E2, which initially showed very low reactions, resulted in one clone 
that was not initially defined as its binding region and one nonsense clone. Thus, this 
antibody was tested in IgG format, which was then able to reproduce the results from 
ORFeome phage display, although other binding regions that are not related to each 
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other were also detected. The last and most intriguing observation of the mapped MSR 
is regarding GSM313-E9 and -H8. As aforementioned, these antibodies were the only 
ones to show 100 % sensitivity and specificity in the indirect ELISA experiments. 
Likewise, these two antibodies were also the only ones to bind a synthetic sequence, 
composed by a mixture of the 1st and 2nd LD. The data for MSR of the scFv-Fc against 
PDC-E2 is part of the Master thesis of Sara Mara Stella Köllner. 
Table 7. Epitope mapping results of the anti-PDC-E2 antibodies used in indirect ELISA. 
Antibody AUC MSR location MSR length 
(amino acids) 
Domain (nº of sequences) 
GSM313-E9 1.0 115-185 71 2nd (12/13), synthetic (1/13) 
LD 
GSM313-H8 1.0 104-188 85 2nd (10/12), synthetic (2/12) 
LD 
GSM313-F5 0.993 115-185 68 2nd LD (14/14) 
GSM313-G5 0.993 103-188 86 2nd LD (11/11) 
GSM130-H1 0.9895 113-188 76 2nd LD (23/23) 
GSM313-
G12 
0.986 108-187 80 2nd LD (11/11) 
GSM313-
D10 
0.9789 5-79, 115-188 74, 74 1st (12/15), 2nd (3/15) LD 
GSM313-C9 0.9579 5-79 74 1st LD (13/13) 
GSM313-D6 0.9439 109-191 83 2nd LD (4/4) 
GSM313-
G11 
0.9439 108-188 81 2nd LD (11/11) 
GSM313-B1 0.9404 108-188 81 2nd LD (11/11) 
GSM134-C1 0.8965 106-192 87 2nd LD (14/14) 
GSM133-A4 0.8947 108-188 81 1st LD (3/21), 2nd LD (18/21) 
GSM313-
H11 
0.8596 232-305 73 PDC-E3 binding domain 
(12/12) 
GSM313-E1 0.8246 NM NM NM 
GSM313-F7 0.7895 3-77, 115-187 73, 75 1st (9/11), 2nd (2/11) LD 
GSM133-E2 0.7789 402-424 23 catalytic domain (1/2), 
nonsense (1/2) 
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GSM133-E2 
(IgG) 
NT 113-145, 301-
359, 526-543 
32, 58, 18 2nd LD (9/11), catalytic 
domain (2/11, different parts) 
GSM313-
B12 
0.7789 5-81 77 1st LD (14/14) 
GSM313-
F10 
0.7158 NM NM NM 
GSM313-
G10 
0.6632 3-78, 113-191 79, 76 1st (6/11), 2nd (5/11) LD 
NM, not mapped. 
NT, not tested. 
 
4.7 scFv-Fc against InlA and InB allow detecting pathogenic Listeria, while 
those against FBA recognize most Listeria spp. with reduced diagnostic 
performance 
The scFv-Fc produced against recombinant InlA or InlB were able to recognize 
the recombinant targets in immunoblot (Fig. 7A), as well as, the three pathogenic 
Listeria tested initially tested (Fig. 7B-F). In indirect ELISA, these antibodies reacted 
only with the three pathogenic L. monocytogenes strains tested, resulting in 100 % 
sensitivity and specificity, with AUC=1.0 (Table 8). On the other hand, the antibodies 
against FBA showed slight distinction between the Listeria spp. and B. subtilis (Fig. 
8). In accordance to this, the diagnostic performance was reduced, since GSM309-
G5 and GSM310-B12 showed AUC=0.807 and 0.8842, respectively. 
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Figure 19. Immunoblot and initial indirect ELISA with anti-InlA and anti-InlB scFv-Fc. (A) Immunoblot of 
GSM30-D2 (anti-InlB) and GSM29-D3, -E6, -G5, and -H8 (anti-InlA) against the recombinant targets. 
(B-F) Titration ELISA with the respective antibodies diluted √10-fold from 10 µg/mL until 3.2 ng/mL. 
Then, they were tested against three strains coated alive onto ELISA plates: L. monocytogenes ATCC 
7644 (L. mono), L. innocua DSM 20649 (L. innocua), and B. subtilis 168 NCIB 10106 (B. subtilis). 
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Table 8. Diagnostic performance of the scFv-Fc targeting InlA, InlB, and FBA.  
Target Antibody Best 
concentrationa 
Sensitivity % 
(CI) 
Specificity % 
(CI) 
AUC (CI) 
InlA GSM29-D3 All tested 100.0 (29.24-
100.0) 
100.0 (88.78-
100.0) 
1.0 (1.0) 
 GSM29-E6 All tested 100.0 (29.24-
100.0) 
100.0 (88.78-
100.0) 
1.0 (1.0) 
 GSM29-G5 All tested 100.0 (29.24-
100.0) 
100.0 (88.78-
100.0) 
1.0 (1.0) 
 GSM29-H8 All tested 100.0 (29.24-
100.0) 
100.0 (88.78-
100.0) 
1.0 (1.0) 
InlB GSM30-D2 All tested 100.0 (29.24-
100.0) 
100.0 (88.78-
100.0) 
1.0 (1.0) 
FBA GSM309-G5 EC50+ 84.21 (60.42-
96.62) 
66.67 (38.38-
88.18) 
0.807 
(0.6627-
0.9513) 
 GSM310-B12 EC50+ 94.74 (73.97-
99.87) 
80.00 (51.91-
95.67) 
0.8842 
(0.76-
1.008) 
 
 
Figure 20. ELISA of the scFv-Fc antibodies against FBA. The monoclonal scFv-Fc GSM309-G5 (A), 
and GSM310-B12 (B) were diluted √10-fold from 10 µg/mL until 3.2 ng/mL. Then, they were tested 
against three strains coated alive onto ELISA plates: L. monocytogenes ATCC 7644 (L. mono), L. 
innocua DSM 20649 (L. innocua), and B. subtilis 168 NCIB 10106 (B. subtilis). 
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The recognition profile of scFv-Fc against FBA shows a similar behavior to that 
from scFv-Fc against PDC-E2. In this case, GSM309-G5 is not able to recognize L. 
aquatica, L. grayi, and L. cornellensis, while reactions against E. faecium, E. lactis, and 
B. cereus were considered positive. In addition, this antibody also shows positive 
reactions against the Gram-negative bacteria P. aeruginosa and K. aerogenes (Fig. 9). 
Similarly, GSM310-B12 did not detect L. aquatica, while showed positive reaction with 
the three Enterococcus species. This way, it is likely that the homology of the target 
has also an influence on the detectability of the strains, since FBA from all strains 
detected as positive, except K. aerogenes, show high homology to Listeria FBA (>50% 
identity). 
 
Figure 21. Reaction profile of four scFv-Fc against InlA, one against InlB, and two against FBA in indirect 
ELISA. Indirect ELISA was done with 19 Listeria strains (dark blue background) and 15 non-Listeria 
strains, including Gram-negative (golden background) and Gram-positive (light blue background). After 
performing a ROC curve analysis, the cut-off value for each antibody was used to determine positive 
(green) and negative (red) reactions. 
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4.8 Single gene phage display results in shorter fragments than ORFeome 
phage display 
It is also worth to note that the size of the isolated fragments with the 4 
antibodies used for ORFeome phage display could be reduced when using epitope 
mapping phage display (Table 9). The scFv-Fc antibodies GSM130-H1 and GSM133-
A4 showed 7.32 and 47.40 %, respectively, smaller MSR in single gene phage display. 
While the IgG GSM133-E2 showed 70.54 % reduction in MSR size. In the case of 
GSM134-C1, the single gene phage display resulted in reactive sequences to 
determine the MSR, what could not be done with ORFeome phage display. The data 
for MSR length of the scFv-Fc against PDC-E2 is part of the Master thesis of Sarah 
Mara Stella Köllner. 
 
Table 9. Comparison of the MSR length between ORFeome phage display and single gene phage 
display. 
Antibody MSR length (amino acids) MSR reduction (%) a 
 ORFeome phage 
display 
Single gene phage 
display 
 
2D12 162 98 39.51 
3F8 18 10 44.44 
GSM130-H1 82 75 8.54 
GSM133-A4 154 79, 88 48.70, 42.86 
GSM133-E2 112 32 b 71.43 
GSM134-C1 NH 87 --- 
NH, no hits. 
a The MSR reduction indicates how much the fragments from single gene phage display are smaller in 
comparison to those from ORFeome phage display. 
b This sequence refers to the MSR in the 2nd LD domain of the IgG molecule, since GSM133-E2 showed 
multiple MSR. 
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5 DISCUSSION 
Phage display is an important technique to study proteins in a library scale, 
making it easier to analyze a vast amount of different molecules at the same time. 
Since antibodies represent the biggest market for biological products, this method is 
nowadays mostly applied to generate antibodies against interesting targets for 
diagnostic and treatment purposes (Frenzel et al., 2017). Nonetheless, phage display 
can also be applied for the study of antigens in order to find biomarkers to be used in 
diagnostics or vaccines (Kügler et al., 2013). In this case, libraries presenting 
fragments of antigens are employed, allowing the automatic detection of interesting 
proteins for application as bioproducts and, thus, giving information about antibody-
antigen recognition. Taking this in consideration this, phage display is a versatile 
technique that allows the generation of antibodies and the discovery of antigens for 
different applications. In this study, however, an unusual combination of the different 
phage display techniques was employed. Initially, antibody phage display was used for 
the discovery of new biomarkers instead of the usually described antigen phage 
display. For this, subcellular fractions from the target species to be detected (L. 
monocytogenes) was used as target at first. This approach resulted in 4 antibodies 
useful for detection, showing that the generation of antibodies against complex protein 
mixtures can also give relevant results. Other works involving viruses, such as Porcine 
Epidemic Diarrhea Virus (Zhang et al., 2019) and Yellow Fever (Daffis et al., 2005), 
and the Gram-negative bacteria Legionella pneumophila (Kuhn et al., 2017), also 
describe the generation of antibodies against multiple proteins as a target. However, 
in the case of viruses, the targets are usually known and their number is diminished 
compared to subcellular fractions. In the case of L. pneumophila, a panning over whole 
cells would represent a much more complex pool of targets. Nevertheless, in this case, 
the Legionella cells were previously treated with formaldehyde, what could have 
impaired the availability of protein targets in the sample and, thus, explaining the 
acquirement of antibodies against lipopolysaccharide (LPS). A similar study employed 
antibody phage display to generate scFv specifically against L. monocytogenes (Paoli 
et al., 2004). The protocol employed live cells as target, and included two different 
strategies with four or seven panning rounds, which resulted in the same binder. 
Another work with L. monocytogenes isolated binders from a peptide library that was 
able to distinguish the pathogenic species (Morton et al., 2013). In this case, the 
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procedure also involved negative and positive selections and 5 panning rounds, 
showing the complexity of the procedure. In accordance to this, even though resulting 
in different antibodies, the present study also reported that the same target was found 
with different panning strategies, showing a possible technical limitation when using 
complex protein mixtures. In summary, this data supports the idea that complex protein 
mixtures, such as whole cells or subcellular fractions, allow the acquisition of useful 
binders in phage display, but in a limited way. 
Conversely, most of the works regarding antibody generation via phage display 
describe the use of purified antigens, indicating that this approach may be more 
successful in providing high-quality antibodies (Rangnoi et al., 2011; Eliyahu et al., 
2018; Fühner et al., 2018; Jalilzadeh-razin et al., 2019; Liu et al., 2019). Thus, after 
identifying the target of the initial four antibodies as PDC-E2, the recombinant version 
of this protein was produced in E. coli and used for another set of antibody panning 
strategies. In fact, more antibodies were generated with this strategy, which resulted 
in 16 new scFv-Fc, compared to 4 from the initial strategy. In accordance with the 
hypothesis that panning over purified antigens can provide higher-quality antibodies, 
four out of the 16 new antibodies showed better diagnostic performance than the best 
of the initial 4 (see Table 6). This way, it is possible to confirm that a “2-step antibody 
phage display” (one against a complex protein mixture, and then against a purified 
target) is recommended when using antibody phage display as an approach for 
biomarker discovery (Fig. 10). 
Another atypical application of a phage display method in this work was 
regarding ORFeome phage display. This technique, which employs a library built with 
antigen fragments from bacterial genomes or cDNA, is often used for the discovery of 
biomarkers that are tested against sera from patients or other source of polyclonal 
antibodies (Connor et al., 2016; Zantow et al., 2016; Zantow et al., 2018; Ramli et al., 
2019). In the present work, however, this technique was employed for a target 
identification purpose, which is usually made or confirmed with MS-based techniques. 
This way, besides the IMS-MS approach to identify the target after the first antibody 
panning, ORFeome phage display was also applied for the identification of the target. 
In this approach, 3 out of the 4 antibodies showed the same target as the IMS-MS 
(Table 5). Only GSM134-C1 showed no positive hit, and GSM133-A4 showed a 
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reaction with a not-related peptide that was further discarded due to low reaction in 
screening ELISA. Considering this, it is possible to affirm that ORFeome phage display 
could provide similar information as IMS-MS regarding target identification, allowing a 
“phage display-only” approach (Fig. 10, right panel). One limitation, however, is that 
more than one antibody may be necessary in case some do not present positive hits 
in screening ELISA, as it was the case of GSM134-C1.  
 
Figure 22. Summary of the workflow with phage display technologies used in this work compared to 
conventional techniques. In studies aiming to develop antibodies and find new biomarkers, some 
standard steps must be followed to characterize either the generated antibodies or the discovered 
antigen. These steps can be achieved with conventional techniques (left workflow), such as hybridoma 
technology, IMS, MS, and peptide membranes or arrays, which have been successfully applied. In the 
present study, the conventional techniques could be replaced by the corresponding phage display 
technique accordingly to the purpose (right workflow). In this phage display approach, IMS-MS was used 
as validation of the results from ORFeome phage display (empty arrow). 
 
After performing the single gene phage display, it was possible to observe that 
most of the scFv-Fc against PDC-E2 showed MSR length ranging from 71 and 87 
amino acids, referring to the approximate size of one of the LD. This indicates that the 
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structure of the domain is essential for recognition. More interestingly, the resulting 
fragments from single gene phage display were smaller than those obtained with 
ORFeome phage display when using the same antibodies. In the present study, the 
size of the MSR from single gene panning showed a reduction of 7-70 % depending 
on the antibody (Table 9). This implies that single gene libraries can in fact give better 
resolution of binding regions when the target of a set of antibodies is already known. 
Besides this, single gene phage display allowed to better characterize the antibodies, 
since it was possible to determine that GSM133-A4 actually recognized both LD of 
PDC-E2 and to determine the MSR of GSM134-C1, which could not be done with 
ORFeome. In an already published work, ORFeome allowed to define the MSR of the 
mAb 3F8 (anti-FBA, hybridoma-derived) as a 25-amino-acid sequence, which fits the 
size of a normal linear epitope (Mendonça et al., 2016). Moreover, the combination of 
ORFeome with peptide membrane immunoblot allowed reducing the size of the 
epitope to 14 amino acids. In the present study, single gene panning was able to 
reduce the MSR length of 3F8 to 10 amino acids (compared to 18 from ORFeome, 
44.44% reduction), making it comparable to other methods, such as the use of peptide 
membranes (Fig. 11). Regarding 2D12 (anti-InlA, hybridoma-derived) and the 
recombinant antibodies against PDC-E2, only protein fragments with 75-162 amino 
acids were able to be detected with either techniques (see Table 9), indicating that 
phage display procedures allow the study of conformational epitopes. Nevertheless, 
the consistency of this difference between these two techniques may be subject of 
further works. Finally, a combination of antibody, ORFeome, and single gene phage 
display (Fig. 10) allowed generating antibodies, identifying a novel biomarker, and 
characterizing antibody-antigen interactions that are useful for Listeria spp. detection. 
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Figure 23. Comparison of 3F8 MSR size between peptide membrane, ORFeome, and single gene 
phage display. (A) In the already published work (Mendonça et al., 2016), a peptide membrane allowed 
reducing the MSR for mAb 3F8 from 25 to 14 amino acids. (B) In this study, ORFeome phage display 
allowed the definition of 3F8 MSR as an 18-amino acid sequence. (C) In the present work, single gene 
phage display allowed defining a region of the MSR of 10 amino acids as the MSR of 3F8. 
 
Considering the structural information of PDC, mainly for PDC-E2, and the 
indirect ELISA results showed in this study, it is possible to observe some correlations. 
The Gram-negative species used in the present work showed no reaction with most of 
the tested antibodies (only GSM313-B12 showed cross-reactivity), supporting the 
already known structural difference of the between Gram-negatives and Gram-
positives. Additionally, the already determined structures of E. faecalis (species used 
in this study) and Geobacillus stearothermophilus present icosahedral symmetry; and 
since Enterecoccus was one of the genus showing most of the cross-reactivity in 
indirect ELISA, it suggests that Listeria spp. possess the same kind of PDC symmetry. 
As to the cellular location, the PDC in eukaryotes acts in the mitochondrial matrix 
after the transport of pyruvate from the cytosol. However, the exact location of the 
complex in the matrix is not fully described and, thus, its proximity to membranes in 
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mitochondria is not clear. Similarly, the PDC in Gram-negatives, as well as in Gram-
positives, is mostly found in the cytosol. Nevertheless, other metabolic proteins, such 
as FBA, are described to be mainly cytoplasmic or attached to the membrane, but are 
also present in the cell wall and, thus, accessible on the bacterial cell surface (Ramnath 
et al., 2003; Mendonça et al., 2016). Likewise, PDC-E2, the core protein of PDC, is 
known to be mainly cytoplasmic, but, in the present study, it was detected in the cell 
wall fraction and showed to be accessible on the bacterial surface, as shown in 
immunoblot, fluorescent microscopy, and indirect ELISA. This indicates that, at least 
in Listeria genus, PDC-E2 behaves similarly to FBA as a protein that is mainly present 
in the cytoplasm but makes its way through the membrane reaching the cell wall and 
surface. Considering this, further studies could address whether other metabolic 
proteins have the same behavior in Gram-positive bacteria.  
Although the metabolic function of PDC is well defined, the importance of this 
protein in some organisms may not have the relevance completely defined in other 
fields. In Mycobacterium tuberculosis, PDC-E2 was found to induce strong cellular 
response in immunocompetent infected population, as well as contributing for the 
resistance of the bacteria against host reactive nitrogen intermediates (Nguyen et al., 
2018). Moreover, it is being studied as a target for antibiotic treatment (Bryk et al., 
2010; Bryk et al., 2013). In Mycobacterium bovis, PDC-E1β was identified as an 
immunodominant antigen in infected cattle, allowing the development of an indirect 
ELISA diagnostic test with better performance than commercial assays (Sun et al., 
2014). The PDC-E1β of Mycobacterium pneumoniae was described to possess 
fibronectin binding activity, allowing the definition of this protein as a moonlighting 
protein (Dallo et al., 2002). In another study, PDC-E1 of Salmonella Enteretidis was 
described as a virulence factor, once mutants with deletions or without the gene 
showed to be less capable of causing important symptoms of the disease (Pang et al., 
2011). Characteristics such as slower growth and increased membrane fluidity also 
occur in PDC-deficient S. aureus, indicating a structural impact of the enzyme (Singh 
et al., 2018). Up to date, no study has shown the impact of PDC from Listeria spp. in 
any of these aspects. Nevertheless, since other metabolic enzymes, such as LAP 
(Jagadeesan et al., 2011), show moonlighting role in Listeria, the possibility of PDC 
presenting additional functions should be further investigated. 
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Regarding the recognition profile of the antibodies against PDC-E2 in indirect 
ELISA, it is possible to observe that some Listeria species show reduced reactions, 
while some non-Listeria species present elevated reactions (Fig. 12). The species L. 
grayi, L. aquatica, and L. cornellensis showed the lowest reactions among the Listeria 
species, with signal-to-noise ratio barely above 1. Although many factors not 
investigated in this study may contribute to the difference in the reactivity, some 
possibilities and observations may be worth of mentioning. Regarding L. grayi, it is 
known that this species is genetically classified in an independent phylogenetic 
subgroup (called Murraya), indicating special characteristics for this bacterium that 
may affect protein expression profile and composition of cell surface (Orsi & 
Wiedmann, 2016). In accordance to this, when analyzing the phylogeny based on 
sequences of PDC-E2, L. grayi also appear isolated from other species of the genus, 
showing the highest genetic change (Fig. 13). In its turn, L. aquatica is part of another 
subgroup (called Mesolisteria) together with L. fleischmannii and L. floridensis. 
Nevertheless, it shares some characteristics with L. grayi, as both are the only two 
species of the genus known to produce acetonin out of glucose metabolism (den 
Bakker et al., 2014). Additionally, both species show similar genetic change and the 
highest when compared to the other species using 325 single-copy genes for analysis 
(Orsi & Wiedmann, 2016). This behavior is also noticed when using PDC-E2 
sequences for phylogeny, once both L. grayi and L. aquatica have the highest genetic 
change (Fig. 13), partially explaining the lower reactivity. As to L. cornellensis, it is 
grouped in a different subgroup (called Paenilisteria). It is worth to highlight that the 
optimal growth of this species in the present study was achieved with 30 °C, instead 
of 37 °C for most of the other species. Curiously, all the species grown under 30 °C in 
this study are part of this subgroup and show to be in the same phylogenetic cluster 
(Orsi & Wiedmann, 2016). In addition, L. cornellensis is the only species that does 
presents a low lactose acidification, although this fact alone may not explain the lower 
reactivity (den Bakker et al., 2014). 
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Figure 24. Signal-to-noise ratio of the 20 antibodies targeting PDC-E2 plotted for each strain. (A) The 
19 Listeria strains were employed to test the sensitivity of the test. Among them, it is important to observe 
that the species L. grayi, L. aquatica, and L. cornellensis were the ones with lowest signal:noise ratio, 
being slightly above the value of 1 (dashed line). (B) The 15 non-Listeria strains were used to determine 
the specificity of the test. Most of them showed low signal:noise ratio, being basically on the value of 1 
(dashed line). Interestingly, the species from genus Bacillus and Enterococcus were the only ones 
presenting considerable reaction with some antibodies, what may indicate that PDC-E2 is also 
accessible on the surface of the cells, and that the protein shows considerable similarity to that one of 
Listeria. Each point of the graphic represent one of the antibodies, which were tested against every 
strain identified in the x-axis. 
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Figure 25. Phylogenetic three of the Listeria spp. used in indirect ELISA based on PDC-E2 protein 
sequence. The GenBank protein codes are described in Table 3. The numbers after the species name 
represent the level of genetic change. 
 
When analyzing the pattern of reactivity of the non-Listeria strains, it is clear that 
species from Bacillus and Enterococcus genus show high reactivity with some of the 
antibodies against PDC-E2. In accordance to this, many works describe Bacillus as 
closely related to Listeria, what strongly indicates phenotypic similarity (Hain et al., 
2006; Chiara et al., 2015). Although phylogenetic comparisons between Listeria and 
Enterococcus are not often made, these organisms may be related enough to share a 
phenotype that can explain the high reactions with some antibodies (Franz et al., 
1999). In addition, PDC-E2 of Bacillus and Enterococcus show considerable identity to 
that of L. monocytogenes (>50 %), what can be also important to determine this 
recognition. The fact that only Gram-positive species showed such reactions may 
indicate that there is a higher tendency of PDC-E2 to be exposed on the cell surface, 
what can be a consequence of the similar structure of PDC in this group of bacteria 
(Izard et al., 1999). In summary, the recognition of PDC-E2 by the antibodies shown in 
this study may depend on multiple factors, such as cellular location of the target 
(phenotype), identity to Listeria PDC-E2, and the overall structure of the complex. 
Regarding FBA recognition, similar effect of homology was observed, once non-
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Listeria species having >50 % identity tend to be recognized by the two tested 
antibodies. More details about this target were part of a previous work (Mendonça et 
al., 2016). 
As to the PDC-E2 region that is recognized by the antibodies used in indirect 
ELISA, it is interesting to notice that the recognition of both LD of PDC-E2 are actually 
not beneficial for the diagnostic performance. Intuitively, if an antibody is able to 
recognize both LD in the same molecule, a higher signal, which can lead to higher 
sensitivity, is expected since twice more antibodies could be bound. Nonetheless, 
although GSM313-F7 shows higher reactions than most of the antibodies, the increase 
on reactivity seems not to be a trend of the antibodies that recognize both LD and does 
not contribute for the sensitivity. Moreover, the recognition of both LD may be 
associated with reduced specificity, since 2 out of the 4 scFv-Fc with this pattern of 
recognition show elevated reactions with non-Listeria species and AUC<0.8 (0.7895 
for GSM313-F7, and 0.6632 for GSM313-G10), putting them in the bottom five in 
diagnostic performance, including the bottom one (see Table 6). The other two 
antibodies were GSM313-D10 and GSM133-A4, which showed AUC=0.9789 and 
0.8947, respectively, but the reasons for their better diagnostic performance were not 
accessed in this study. 
Other interesting pattern of recognition occurred with the best two scFv-Fc in 
diagnostic performance. Both GSM313-E9 and GSM313-H8 recognized the 1st LD and 
a synthetic LD formed by the fusion of the two LD of PDC-E2, which was probably a 
result of the random fragmentation and ligation during the library construction. 
Unfortunately, the reason of the correlation between reactivity with this synthetic 
sequence and improvement of diagnostic performance cannot be addressed with the 
results in the present work. Thus, it may be object of investigation of further studies. 
The case of GSM133-E2 is also worth of mentioning, since this antibody is specific for 
PDC-E2, but presents multiple binding sites, possibly exemplifying a case of 
multispecificity. Multispecific antibodies are known to recognize more than one epitope 
with the same CDR with high specificity (James & Tawfik, 2003; James et al., 2003; 
Mariuzza, 2006). Although most of the cross-reactions are explained to occur due to 
hydrophobic interactions, which lead to unspecificity, multispecificity is composed of 
strong interactions such as hydrogen bonds. In fact, the detected peptides out of the 
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LD regions show higher hydrophobic composition (45-55 % of the amino acids, 
compared to ≈40% in the LD regions), although it is not excessively elevated 
considering that highly hydrophobic peptides present >50 % of hydrophobic amino 
acids and <25 % acidic composition (Hoofnagle et al., 2017). Besides this, although 
peptide properties can be rather complex (Malavolta et al., 2006), all peptides 
represent regions of the protein surface that may be mostly soluble in aqueous 
solution. This way, it is probable that GSM133-E2 is not intrinsically unspecific, but 
shows a multispecificity that lowers its diagnostic performance. If this were the case, it 
would be the first reported multispecific antibody generated from a human naïve 
antibody phage display library that binds different parts of the same target. However, 
similar to the cases of GSM313-E9 and GSM313-H8, further investigation is necessary 
to determine the cause and details of such event. 
As aforementioned, InlA and InlB are the main studied targets when it comes to 
detecting L. monocytogenes. Previous studies characterized monoclonal antibodies 
against, including a scFv against InlB, by showing their application in fluorescence-
based detection (Tully et al., 2006). Other works used an aptamer against InlA for the 
detection of the pathogenic species using a biosensor (Ohk et al., 2010). In this case, 
the method was able to selectively recognize L. monocytogenes from artificially 
contaminated food In its turn, InlB was used as a target to generate an VHH (variable 
domain of the heavy chain) antibody from Camelidae libraries (MacKenzie et al., 2014). 
However, this antibody was not extensively tested regarding its diagnostic 
performance, since only recombinant InlA was used as negative control for cross-
reaction. In the present work, although the panel of L. monocytogenes strains was not 
big, since it included three strains representing the three more prevalent serovars in 
clinical cases (Orsi et al., 2011), no reaction against the other 31 species tested, 
indicating its high applicability for detection. As to the limit of detection (LOD), 
commercial lateral flow tests are able to detect 104-106 CFU/mL, while efforts to reduce 
this number were not completely successful (Shi et al., 2014). In this work, the LOD for 
each antibody was not investigated once the final assay would involve the use of lateral 
flow assays or biosensors that could not be accessed at the moment of the research. 
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6 CONCLUSION AND OUTLOOK 
The genus Listeria has gained more attention in the past years due to the 
description of new species, what led to an increase on the number of studies over its 
genetics and phenotypes. Summed to this, the pathogenic species L. monocytogenes 
is still a major concern over the public health once it is still the agent of many food 
contamination outbreaks around the world. This way, studies over Listeria spp. and 
how to detect it are of interest to help defining the new characteristics of the bacteria 
and to avoid problems with food contamination. In the present work, a novel target for 
the detection of Listeria spp. (i.e. PDC-E2) is described, increasing the list of enzymatic 
targets that can be used for the detection of such bacteria. This may open new 
research over the applicability of PDC-E2 in biological products. Besides this, two 
antibodies against this target showed to bind specifically the genus Listeria, allowing 
further studies over the target and the generation of immunodetection methods for 
increasing food safety. In addition, different combinations of phage display techniques 
were applied in order to perform biomarker discovery and identification, antibody 
generation, and epitope mapping, opening way to new applications of phage display 
technology. The comparison between ORFeome and single gene phage may still be 
topic of further works, which will help to elucidate the complete application of such 
technologies, especially on the field of antigen-antibody interaction. As to the 
antibodies generated against PDC-E2, it is expected to further investigate the reason 
why the best antibodies are the only ones able to recognize a synthetic fragment of 
PDC-E2. In addition, the GSM133-E2 case may receive more attention since it can 
provide further knowledge over the output of antibody phage display. Finally, it is 
expected that the biological tools generated in this study, mainly the antibodies against 
PDC-E2, InlA, and InlB, will be used in diagnostic assays that can generate a biological 
product, such as lateral flow assays. 
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